Silver Book

References

Loading...
Search References:
No results to display
    Author(s) Title
    Hansen D, Bazell C, Pelizzari P, Pyenson B‌ Medicare Cost of Osteoporotic Fractures‌
    Pietzsch J, Garner A, Marks W‌ Cost Effectiveness of Deep Brain Stimulation for Advanced Parkinson’s Disease in the United States‌
    Van Den Eeden S, Tanner C, Bernstein A, et al‌ Incidence of Parkinson’s Disease: Variation by age, gender, and race/ethnicity‌
    Tandberg E, Larsen J, Aarsland D, Cummings J‌ The Occurrence of Depression in Parkinson’s Disease: A community-based study‌
    Scheiss M, Suescun J, Ellmore T, et al‌ Preliminary Report on the Safety and Tolerability of Bone Marrow-Derived Allogenic Mesenchymal Stem Cells Infused Intravenously in Parkinson’s Disease Patients‌
    Samotus O, Parrent A, Jog M‌ Spinal Cord Stimulation Therapy for Gait Dysfunction in Advanced Parkinson’s Disease‌
    Safarpour D, Thibault D, DeSanto C, Boyd C, et al.‌ Nursing Home and End-of-Life Care in Parkinson Disease‌
    Ravina B, Camicioli R, Como P‌ The Impact of Depressive Symptoms in Early Parkinson Disease‌
    Pietzsch J, Garner A, Marks W‌ Cost Effectiveness of Deep Brain Stimulation for Advanced Parkinson’s Disease in the United States‌
    Parkinson's Foundation‌ Parkinson’s Foundation Statistics‌
    O'Brien J, Ward A, Michels S, Tzivelekis S‌ Economic Burden Associated with Parkinson Disease‌
    National Institute of Neurological Disorders and Stroke‌ Parkinson’s Disease: Challenges, progress, and promise‌
    Melton L, Leibson C, Achenbach S, Bower J, et al.‌ Fracture Risk After Diagnosis of Parkinson’s Disease: Influence of concomitant dementia‌
    Marras C, Beck J, Bower J, Roberts E, et al.‌ Prevalence of Parkinson’s Disease Across America‌
    Lopes J‌ AXO-Lenti-PD Gene Therapy Shows Benefits in 2 Advanced Parkinson’s Patients in Phase 1/2 Trial‌
    Kowal S, Dall T, Jain A‌ The Current and Projected Economic Burden of Parkinson’s Disease in the United States‌
    Johnson S, Diener M, Kaltenboeck A, Birnbaum H, et al.‌ An Economic Model of Parkinson’s Disease: Implications for slowing progression in the United States‌
    Hamilton J, The Michael J. Fox Foundation for Parkinson's Research, Yang W, The Lewin Group, et al.‌ The Economic Burden of Parkinson’s Disease‌
    Forsaa E, Larsen J, Wentzel-Larsen T, Goetz C, et al.‌ A 12-Year Population-Based Study of Psychosis in Parkinson’s Disease‌
    Christine C, Bankiewicz K, Van Laar A, Richardson R, et al.‌ Magnetic Resonance Imaging-Guided Phase 1 Trial of Putanimal AADC Gene Therapy for Parkinson’s Disease‌
    Biundo R, Weis L, Antonini A‌ Cognitive Decline in Parkinson’s Disease: The complex picture‌
    America's Biopharmaceutical Companies‌ Medicines in Development for Neurological Disorders: 2018 Report‌
    Allen N, Schwarzel A, Canning C‌ Recurrent Falls in Parkinson’s Disease: A systemic review‌
    Benjamin E, Virani S, Callaway C, et al‌ Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association‌
    Administration on Aging‌ A Profile of Older Americans: 2018‌
    Kato E, Ngo-Metzger Q, Fingar K, McDermott K, et al.‌ Inpatient Stays Involving Atrial Fibrillation, 1998 – 2014‌
    Lim D, Reynolds M, Feldman T, Kar S, et al.‌ Improved Functional Status and Quality of Life in Prohibitive Surgical Risk Patients with Degenerative Mitral Regurgitation After Transcatheter Mitral Valve Repair‌
    Stuntz M‌ Mitral Valve Disease in the United States: Retrospective analysis of hospitalizations and surgical procedures using the National Inpatient Sample (World Congress on Heart Disease Abstract)‌
    Barbieri A, Bursi F, Grigioni F, et al‌ Prognostic and Therapeutic Implications of Pulmonary Hypertension Complicating Degenerative Mitral Regurgitation Due to Flail Leaflet‌
    D'Arcy J, Coffey S, Loudon M, Kennedy A, et al.‌ Large-Scale Community Echocardiographic Screening Reveals a Major Burden of Undiagnosed Valvular Heart Disease in Older People‌
    Vassileva C, Mishkel G, McNeely C, et al‌ Long-Term Survival of Patients Undergoing Mitral Valve Repair and Replacement: A longitudinal analysis of Medicare fee-for-service beneficiaries‌
    Goel S, Bajaj N, Agaarwall B, Gupta S, et al.‌ Prevalence and Outcomes of Unoperated Patients with Severe Symptomatic Mitral Regurgitation and Heart Failure‌
    Beldon Russonello Strategists, on behalf of the Alliance for Aging Research‌ Report of Findings from Opinion Research Among Heart Valve Disease Patients‌
    Moore M, Chen J, Mallow P, Rizzo J‌ The Direct Health-Care Burden of Valvular Heart Disease: Evidence from US national survey data‌
    Bach D, Radeva J, Birnbaum H, Fournier A, Tuttle E‌ Prevalence, Referral Patterns, Testing, and Surgery in Aortic Valve Disease: Leaving women and elderly patients behind?‌
    Reynolds M, Lei Y, Wang K, Chinnakondepalli K, et al.‌ Cost-Effectiveness of Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement‌
    Wu Y, Jin R, Gao G, Grunkmeier G, Starr A‌ Cost-Effectiveness of Aortic Valve Replacement in the Elderly: An introductory story‌
    Wu Y, Grunkmeier G, Starr A‌ The Value of Aortic Valve Replacement in Elderly Patients: An economic analysis‌
    Baron S, Arnold S, Wang K, et al‌ Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis at Intermediate Risk: Results from PARTNER 2 Randomized Clinical Trial‌
    Bach D‌ Prevalence & Characteristics of Unoperated Patients with Severe AS Awareness of HVD The‌
    Kovac J, Schuler G, Gerckens U, Muller R, et al.‌ Four-Year Experience with CoreValve Transcatheter Heart Valve‌
    Vukanovic-Criley J, Criley S, Warde C, et al‌ Competency in Cardiac Examination Skills in Medical Students, Trainees, Physicians, and Faculty‌
    Kodali S, Thourani V, White J, Malaisrie S, et al.‌ Early Clinical and Echocardiographic Outcomes After SAPIEN 3 Transcatheter Aortic Valve Replacement in Inoperable, High-Risk and Intermediate-Risk Patients with Aortic Stenosis‌
    Grover F, Vemalapalli S, Carroll J, Edwards F, et al.‌ 2016 Annual Report of The Society for Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry‌
    Thourani V, Kodali S, Makkar R, et al‌ Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Intermediate-Risk Patients: A propensity score analysis‌
    Belden Russanello Strategists‌ Report of Findings from Opinion Research among Heart Valve Disease Patients‌
    Varadarajan P, Kapoor N, Bansal R, Pai R‌ Survival in Elderly Patients with Severe Aortic Stenosis is Dramatically Improved by Aortic Valve Replacement: Results from a cohort of 233 patients aged ≥ 80 years‌
    Clark M, Duhay F, Thompson A, Keyes M, et al.‌ Clinical and Economic Outcomes After Surgical Aortic Valve Replacement in Medicare Patients‌
    Benjamin E, Blaha M, Chiuve S, et al‌ Heart Disease and Stroke Statistics — 2017 Update: A report from the American Heart Association‌
    Malaisrie C, McDonald E, Kruse J, Li Z, et al.‌ Mortality While Waiting for Aortic Valve Replacement‌
    Clark M, Arnold S, Duhay F, Thompson A, et al.‌ Five-Year Clinical and Economic Outcomes Among Patients with Medically Managed Severe Aortic Stenosis: Results from a Medicare claims analysis‌
    Otto C‌ Timing of Aortic Valve Surgery‌
    Osnabrugge R, Mylotte D, Head S, Van Meighem N, et al.‌ Aortic Stenosis in the Elderly: Disease prevalence and number of candidates for transcathet aortic valve replacement, a meta-analysis and modeling study.‌
    D'Arcy J, Coffeey S, Loudon M, et al‌ Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study‌
    Mesothelioma.net‌ Mesothelioma Information and Facts‌
    Alzheimer's Association‌ 2017 Alzheimer’s Disease Facts and Figures‌
    Benjamin E, Blaha M, Chiuve S, Cushman M, et al‌ Heart Disease and Stroke Statistics- 2017 Update‌
    Chang C, Fine M, Yende S, Balakumar V, et al. V‌ Proportion and Cost of Unplanned 30-Day Readmissions After Sepsis Compared With Other Medical Conditions‌
    Fedearl Interagency Forum on Aging-Related Statistics‌ Older Americans 2016: Key indicators of well-being‌
    Ozawa S, Portney A, Getaneh H, Clark S, et al.‌ Modeling the Economic Burden of Adult Vaccine-Preventable In the United States‌
    Scott A, Bressler N, Ffolkes S, et al.‌ Public Attitudes About Eye and Vision Health‌
    Prescott H, Osterholzer J, Langa K, Angus D, et al.‌ Late Mortality After Sepsis: Propensity matched cohort study‌
    Varma R, Vajaranat T, Burkemper B, Wu S, et al.‌ Visual Impairment and Blindness in Adults in the United States: Demographic and geographic variations from 2015 to 2050‌
    Zheng Y, He M, Congdon N‌ The Worldwide Epidemic of Retinopathy‌
    Zhang X, Saaddine J, Chou C, Cotch M, et al‌ Prevalence of Diabetic Retinopathy in the United States, 2005 – 2008‌
    Yau J, Rogers S, Kawasaki R, Lamoreaux E, et al‌ Global Prevalence and Major Risk Factors of Diabetic Retinopathy‌
    Xie X, Xu L, Jonas J, Wang Y‌ Prevalence of Diabetic Retinopathy Among Subjects with Known Diabetes in China: The Beijing Eye Study‌
    World Health Organization‌ Prevention of Blindness from Diabetes Mellitus: Report of a WHO consultation‌
    Wong T, Cheung N, Tay W, Wang J, et al‌ Prevalence and Risk Factors for Diabetic Retinopathy: The Singapore Malay Eye Study‌
    Villena J, Yoshiyama C, Sanchez J, Hilario N, et al‌ Prevalence of Diabetic Retinopathy in Peruvian Patients with Type 2 Diabetes: Result of a hospital-based retinal telescreening program‌
    UK Prospective Diabetes Study Group‌ Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes: UKPDS 38‌
    Rubino A, Rousculp M, Davis K, Wang J, Girach A‌ Diagnosed Diabetic Retinopathy in France, Italy, Spain, and the United Kingdom‌
    Resnikoff S, Felch W, Gauthier T, Spivey B‌ The Number of Ophthalmologists in Practice and Training Worldwide: A growing gap despite more than 200,000 practitioners‌
    Raman R, Rani P, Rachepalle S, Ghanamoorthy P, et al‌ Prevalence of Diabetic Retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study Report 2‌
    Polack S, Yorston D, Lopez-Ramos A, Lepe-Orta S, et al‌ Rapid Assessment of Avoidable Blindness and Diabetic Retinopathy in Chiapas, Mexico‌
    Pershing S, Enns E, Matesic B, Owens D, et al.‌ Cost-Effectiveness of Treatment of Diabetic Macular Edema‌
    Paudyal G, Shrestha M, Meyer J, et al‌ Prevalence of Diabetic Retinopathy Following Community Screening for Diabetes‌
    Papili'i-Curtin A, Dalziel D‌ Prevalence of Diabetic Retinopathy and Maculopathy in Northland, New Zealand: 2011-2012‌
    McKay R, McCarty C, Taylor H‌ Diabetic Retinopathy in Victoria, Australia: The visual impairment project‌
    Mash B, Powell D, du Pelssis F, van Vuuren U, et al.‌ Screening for Diabetic Retinopathy in Primary Care with a Mobile Fundal Camera: Evaluation of a South African pilot project‌
    Mackey T, Khater N, Al-Zamil M, El Fishawy H, et al.‌ Epidemiology of Diabetic Retinopathy in Egypt: A hospital-based study‌
    Lighthouse International‌ Diabetic Retinopathy Treatment and Care‌
    Lang G‌ Laser Treatment of Diabetic Retinopathy‌
    Kilstad H, Sjolie A, Goransson L, Hapnes R, et al.‌ Prevalence of Diabetic Retinopathy in Norway: Report from a screening study‌
    Khan A, Wiseberg J, Lateer Z, Khan S‌ Prevalence and Determinants of Diabetic Retinopathy in Al Hasa Region of Saudi Arabia: Primary health care centre based cross-sectional survey, 2007-2009‌
    Jivraj I, Ng M, Rudnisky C, Dimla B, et al.‌ Prevalence and Severity of Diabetic Retinopathy in Northwest Cameroon as Identified by Teleophthalmology‌
    Javadi M, Katibeh M, Rafati N, Dehghan M, et al.‌ Prevalence of Diabetic Retinopathy in Tehran Province: A population-based study‌
    International Diabetes Federation‌ IDF Diabetes Atlas, 6th Edition‌
    International Council of Ophthalmology‌ Guidelines for Diabetic Eye Care‌
    Hex N, Bartlett C, Wright D, Taylor M, et al.‌ Estimating the Current and Future Costs of Type 1 and Type 2 Diabetes in the UK: Including direct health costs and indirect societal and productivity costs‌
    Heintz E, Wirehn A, Peebo B, Rosenqvist U, et al.‌ Prevalence and Healthcare Costs of Diabetic Retinopathy: A population-based register study in Sweden‌
    Hautala N, Aikkila R, Korpelainan J, Keskitalo A, et al.‌ Marked Reductions in Visual Impairment Due to Diabetic Retinopathy Achieved by Efficient Screening and Timely Treatment‌
    Happich M, Reitberger U, Breitscheidel L, Ulbig M, et al.‌ The Economic Burden of Diabetic Retinopathy in Germany in 2002‌
    Gonzalez J, Walker J, Einarson T‌ Cost-of-Illness Study of Type 2 Diabetes Mellitus in Colombia‌
    Gill G, Gebrekidan A, English P, Wile D, et al.‌ Diabetic Complications and Glycaemic Control in Remote North Africa‌
    Garg S, Jani P, Kshirsagar A, King B, et al.‌ Telemedicine and Retinal Imaging for Improving Diabetic Retinopathy Evaluation‌
    Friedman D‌ Vision Problems in the U.S.: Prevalence of adult vision impairment and age-related eye disease in America 5th Edition‌
    Ferguson T, Tulloch-Reid M, Wilks R‌ The Epidemiology of Diabetes Mellitus in Jamaica and the Caribbean: A historical review‌
    Fenwick E, Rees G, Pesudovs K, Dirani M, et al.‌ Social and Emotional Impact of Diabetic Retinopathy: A review‌
    Dedov I, Maslova O, Suntsov Y, Bolotskaia L, et al.‌ Prevalence of Diabetic Retinopathy and Cataract in Adult Patients with Type 1 and Type 2 Diabetes in Russia‌
    Brown D, Nguyen Q, Marcus D, Boyer D, et al.‌ Long-Term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-month results from two phase III trials: RISE and RIDE‌
    Brown M, Brown G, Sharma S, Shah G‌ Utility Values and Diabetic Retinopathy‌
    Bressler N, Chang T, Fine J, Dolan C, et al.‌ Vision-Related Function after Ranibizumab Treatment by Better- or Worse-Seeing Eye: Clinical trial results from MARINA and ANCHOR‌
    Brian G, Fischer-Harder K, Sikivou B, Qoqonokana M, et al.‌ Diabetic Eye Disease Among Adults in Fiji with Self-Reported Diabetes‌
    Bourne R, Stevens G, White R, Smith J, et al.‌ Causes of Vision Loss Worldwide, 1990-2010: A systematic analysis‌
    Barcelo A, Aedo C, Rajpathak S, Robles S‌ The Cost of Diabetes in Latin America and the Caribbean‌
    Bamushmus M, Gunaid A, Khandekar R‌ Diabetic Retinopathy, Visual Impairment, and Ocular Status Among Patients with Diabetes Mellitus in Yemen: A hospital-based study‌
    Andonegui J, Serrano L, Eguzkiza A, Barastegui L, et al‌ Diabetic Retinopathy Screening Using Tele-Ophthalmology in a Primary Care Setting‌
    AdvaMed‌ The Value of MedTech: To treat afib‌
    Kelley A, McGarry K, Gorges R, Skinner J‌ The Burden of Health Care Costs for Patients with Dementia in the Last 5 Years of Life‌
    American Association for Cancer Research‌ AACR Cancer Progress Report 2015: Transforming lives through precision medicine‌
    American Diabetes Association‌ Eye Complications‌
    Centers for Disease Control and Prevention, National Center for Chronic Disease and Health Promotion‌ National Diabetes Statistics Report, 2014: Estimates of diabetes and its burden in the United States‌
    Kelley A, McGarry K, Gorges R, Skinner J‌ The Burden of Health Care Costs for Patients With Dementia in the Last 5 Years of Life‌
    National Center for Chronic Disease Prevention and Health Promotion‌ National Diabetes Statistics Report, 2014‌
    Lasker R‌ The Diabetes Control and Complications Trial: Implications for policy and practice‌
    Adler A, Stratton I, Weil H, Yudkin J, et al‌ Association of Systolic Blood Pressure with Macrovascular and Microvascular Complications of Type 2 Diabetes (UKPDS 36): Prospective observational study‌
    Centers for Disease Control & Prevention‌ National Diabetes Fact Sheet‌
    National Institute of Diabetes and Digestive and Kidney Disease‌ Diabetic Neuropathies: The nerve damage of diabetes‌
    Marchetti A, Rossiter R‌ Economic Burden of Healthcare-associated Infection in US Acute Care Hospitals: Societal perspective‌
    Ott A‌ Atrial Fibrillation and Dementia in a Population-Based Study: The Rotterdam Study‌
    Pew Research Center‌ Baby Boomers Retire‌
    McGlynn E, Asch S, Adams J, Keesey J, et al.‌ The Quality of Health Care Delivered to Adults in the United States‌
    Lee W, Lamas G, Balu S, Spalding J, et al.‌ Direct Treatment Cost of Atrial Fibrillation in the Elderly American Population: A Medicare perspective‌
    Lamassa M, Di Carlo A, Pracucci G, Basile A, et al.‌ Characteristics, Outcome, and Care of Stroke Associated with Atrial Fibrillation in Europe: Data from a multicenter multinational hospital based registry (The European Community Stroke Project)‌
    Dulli D, Stanko H, Levine R‌ Atrial Fibrillation is Associated with Severe Acute Ischemic Stroke‌
    Coyne KS, Paramore C, Grandy S, Mercader M, et al.‌ Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States‌
    Miyasaka Y, Barnes M, Gersch B, Cha S, et al. K‌ Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence‌
    Go A, Hylek E, Phillips K, Chang Y, et al.‌ Prevalence of Diagnosed Atrial Fibrillation in Adults: National implications for rhythm management and stroke prevention: The AnTicoagulation & Risk Factors in Atrial Fibrillation (ATRIA) Study‌
    Fanikos J, Grasso-Correnti N, Shah R, Kucher N, et al.‌ Major Bleeding Complications in a Specialized Anticoagulation Service‌
    Centers for Disease Control and Prevention‌ National diabetes fact sheet: general information and national estimates on diabetes in the United States‌
    American Diabetes Association‌ Economic Costs of Diabetes in the U.S. in 2012‌
    U.S. Census Bureau‌ The Next Four Decades: The older population in the United States: 2010 to 2050‌
    National Foundation to End Senior Hunger‌ The State of Senior Hunger in America in 2013: An Annual Report‌
    National Council on Aging‌ National Council on Aging, Fact Sheet, Health Aging, 2014‌
    U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion‌ Healthy People 2020, Older Adults, National Snapshots‌
    U.S. Census Bureau‌ 2012 National Population Projections‌
    Administration on Aging‌ A Profile of Older Americans: 2014‌
    Federal Interagency Forum on Aging-Related Statistics‌ Older Americans 2012: Key Indicators on Well-Being‌
    Centers for Disease Control and Prevention, National Center for Health Statistics‌ Health, United States, 2014 with Special Feature on Adults Aged 55-64‌
    Administration on Aging‌ A Profile of Older Americans: 2005‌
    National Alliance for Caregiving‌ Caregiving in the U.S‌
    National Center for Health Statistics‌ Health, United States, 2013 With Special Feature on Prescription Drugs‌
    American Association for Cancer Research‌ AACR Cancer Progress Report 2014‌
    Murphy K, Topel R‌ The Value of Health and Longevity‌
    Long, G and J Works‌ Innovation in the Biopharmaceutical Pipeline: A multidimensional view.‌
    Lakdawala D, Sun E, Jena A, Reyes C, et al.‌ An Economic Evaluation of the War on Cancer‌
    Stockdale H, Guillory K‌ Lifeline: Why cancer patients depend on Medicare for critical coverage‌
    Zafara S, Peppercorna J, Taylor D, Goetzingerd A, et al‌ The Financial Toxicity of Cancer Treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience‌
    National Heart, Lung, and Blood Institute‌ NHLBI Fact Book, Fiscal Year 2012‌
    National Cancer Institute‌ SEER Cancer Statistics Review, 1975-2005‌
    American Association for Cancer Research‌ AACR Cancer Progress Report 2013‌
    Munoz J, Kurzrock R‌ Targeted Therapy in Rare Cancers: Adopting the orphans‌
    Mariotto A, Yarboff K, Shao Y, Feuer E, et al.‌ Projections of the Cost of Cancer Care in the U.S.: 2010-2020‌
    Tang, D, D Alberts, R Nevins, S Sullivan, and G Skrepnek‌ Health Care Expenditures, Hospitalizations, and Productivity Associated with Cancer in U.S. Employer Settings‌
    Bloom D, Cafiero E, Jane-Llopis E, Abrahams-Gessel S, et al‌ The Global Economic Burden of Non-Communicable Diseases‌
    Yabaroff K, Bradley A, Mariotto A, Brown M, et al‌ Estimates and Projections of Value of Life Lost from Cancer Deaths in the United States‌
    DeSantis C, Lin C, Mariotto A, Siegel R, et al.‌ Cancer Treatment and Survivorship Statistics, 2014‌
    Gross, T, E Picard, and A Tarab‌ Recognizing Value in Oncology Innovation‌
    Jemal, A, E Ward, and M Thun‌ Declining Death Rates Reflect Progress Against Cance‌
    Sun E, Lakdawall D, Ryes C, Goldman D, et al‌ The Determinants of Recent Gains in Cancer Survival: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database‌
    Lichtenberg F‌ The Expanding Pharmaceutical Arsenal in the War on Cancer‌
    Siegel R, Ward E, Brawley O, Jemal A‌ Cancer Statistics, 2011: The impact of eliminating socioecomic and racial disparities on premature cancer deaths‌
    American Cancer Society‌ Breast Cancer Facts & Figures 2011-2012‌
    Murphy S, Xu J, Kochanek K‌ Deaths: Final data for 2010‌
    Hayat, M, N Howlader, M Reichman, and B Edwards‌ Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program‌
    American Cancer Society‌ Cancer Treatment and Survivorship Facts & Figures 2014-2015‌
    Berry, D, K Cronin, S Plevritis, D Fryback, L Clarke, et al.‌ Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer‌
    Romond E, Perez E, Bryant J, Suman V, et al.‌ Tastuzumab Plus Adjuvant Chemotherapy for Operable HER-2 Positive Breast Cancer‌
    Ferlay J, Ervik M, Dikshit R, Eser S, et al.‌ Latest world cancer statistics – GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012‌
    American Cancer Society‌ Cancer Facts & Figures 2015‌
    Howlader N, Noone A, Krapcho M, Garshell J, et al.‌ SEER Cancer Statistics Review, 1975-2011‌
    Ramsey S, Blough D, Kirchoff A, Kreizenbeck K, et al.‌ Washington State Cancer Patients Found to be at Greater Risk for Bankruptcy than People without a Cancer Diagnosis‌
    Aspinall, M and R Hamermesh‌ Realizing the Promise of Personalized Medicine‌
    Lichtenberg F‌ The Expanding Pharmaceutical Arsenal in the War on Cancer‌
    Kupelian P, Potters L, Khuntia D, Ciezki J‌ Radical Prostatectomy, External Beam Radiotherapy <72 Gy, External Beam Radiotherapy > or =72 Gy, Permanent Seed Implantation, or Combined Seeds/External Beam Radiotherapy for Stage T1-T2 Prostate Cancer‌
    Kantoff P, Higano C, Shore N, Berger E, et al.‌ Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer‌
    IMS Institute for Health Informatics‌ Declining Medicine Use and Costs: For better or for worse? A review of the use of medicines in the United States in 2012‌
    Guy G, Ekwueme D, Yabroff K, Dowling E, et al.‌ Economic Burden of Cancer Survivorship Among Adults in the United States‌
    National Cancer Institute‌ Cancer Trends Progress Report‌
    Goldman D, Joyce G, Lawless G, Crown W, et al.‌ Benefit Design and Specialty Drug Use‌
    Ekwuekme D, Yabroff K, Guy G, Banegas M, et al.‌ Medical Costs and Productivity Losses of Cancer Survivors: United States, 2008-2011‌
    Agency for Healthcare Research and Quality‌ Medical Expenditure Panel Survey‌
    National Heart, Lung, and Blood Institute‌ NHLBI Fact Book, Fiscal Year 2012‌
    Van Ryn M, Sanders S, Kahn K, von Houtven C, et al‌ Objective Burden, Resources, and Other Stressors Among Informal Cancer Caregivers: A hidden quality issue?‌
    National Cancer Institute‌ Depression‌
    Van den Beuken-van Everdingen M, de Rijke J, Kessels A, Schouten H, et al‌ Prevalence of Pain in Patients with Cancer: A systematic review of the past 40 years‌
    Shi Q, Smith T, Michonski J, Stein K, et al‌ Symptom Burden in Cancer Survivors 1 Year After Diagnosis: A report from the American Cancer Society’s studies of cancer survivors‌
    Lievre A, Bachet J, Boige V, Cayre A, et al.‌ KRAS Mutations as an Independent Prognostic Factor in Patients with Advanced Colorectal Cancer Treated with Cetuximab‌
    Philipson T, Eber M, Lakdawalla D, Corral M, et al.‌ An Analysis of Whether Higher Health Care Spending is Worth it in the Case of Cancer‌
    Xu J, Murphy S, Kochanek K, Bastian B‌ Deaths: Final data for 2013‌
    Centers for Disease Control and Prevention‌ United States Cancer Statistics: 1999-2011 Incidence and Mortality Web-based Report‌
    Parry C, Kent E, Mariotto A, Alfano C, et al.‌ Cancer Survivors: A booming population‌
    Murphy K, Topel R‌ Measuring the Gains from Medical Research: An economic approach‌
    Bradley C, Yabroff K, Dahman B, Feuer E, et al.‌ Productivity Costs of Cancer Mortality in the United States: 2000-2020‌
    Colditz G, Wei E‌ Preventability of Cancer: The relative contributions of biologic and social and physical environmental determinants of cancer mortality‌
    De Martel C, Ferlay J, Granceschi S, Vignat J, et al.‌ Global Burden of Cancers Attributable to Infections in 2008: A review and synthetic analysis‌
    Centers for Disease Control & Prevention‌ Vital Signs: Colorectal cancer screening, incidence, and mortality – United States, 2002-2010‌
    National Cancer Institute‌ What Is Cancer?‌
    Wang G, Joo H, Tong X, George M‌ Hospital Costs Associated with Atrial Fibrillation for Patients with Ischemic Stroke Aged 18-64 Years in the United States‌
    Nkomo V, Gardin J, Skelton T, Gottdiener J, et al.‌ Burden of Valvular Heart Diseases: A population-based study‌
    Glaucoma Research Foundation‌ Glaucoma Facts and Stats‌
    American Cancer Society‌ Cancer Facts & Figures 2014‌
    MetLife Mature Market Institute‌ The MetLife Study of Caregiving Costs to Working Caregivers: Double jeopardy for baby boomers caring for their parents‌
    National Alliance for Caregiving‌ Caregiving in the U.S‌
    Feinberg L, Reinhard S, Houser A, Choula R‌ Valuing the Invaluable: 2011 Update–the growing contributions and costs of family caregiving‌
    Pharmaceutical Research and Manufacturers of America‌ Vaccine Fact Book 2013‌
    Pharmaceutical Researchers and Manufacturers of America‌ Medicines in Development: Vaccines–A report in the prevention and treatment of disease through vaccines‌
    Towse A, Sharma P‌ Incentives for R&D for New Antimicrobial Drugs: Research paper 11/02‌
    Spellberg B, Guidos R, Gilbert D, Bradley J, et al‌ The Epidemic of Antibiotic-Resistant Infections: A call to action for the medical community from the Infectious Diseases Society of America‌
    Infectious Diseases Society of America‌ Bad Drugs, No Drugs: As antibiotic discovery stagnates…a public health crisis brews‌
    National Nosocomial Infections Surveillance (NNIS) System‌ National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990 – May 1999, Issued June 1999‌
    Klevens R, Edwards J, Richards C, Horan T, et al.‌ Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002‌
    Infectious Diseases Society of America‌ Combating Antimicrobial Resistance: Policy recommendations to save lives‌
    Lucado J, Paez K, Andrews R, Steiner C‌ Adult Hospital Stays with Infections Due to Medical Care, 2007‌
    Braykov N, Eber M, Klein E, Morgan D, et al.‌ Trends in Resistance to Carbapenems and Third-Generation Cephalasporins Among Clinical Isolates of Klebsiella Pneumoniae in the United States, 1999-2010‌
    Centers for Disease Control and Prevention‌ Making Health Care Safer: Stopping C. difficile infections‌
    Hall M, Williams S, DeFrances C, Golosinskiy A‌ Inpatient Care for Septicemia or Sepsis: A challenge for patients and hospitals‌
    Haley R, Hooton T, Culver D, Stanley R, et al.‌ Nosocomial Infections in U.S. Hospitals, 1975-1976‌
    Douglas S‌ The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention‌
    Hidron A, Edwards J, Patel J, Horan T, et al.‌ Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007‌
    Agency for Healthcare Research and Quality‌ AHRQ’s Efforts to Prevent and Reduce Health Care-Associated Infections: Fact sheet‌
    Infectious Diseases Society of America‌ Promoting Anti-Infective Development and Antimicrobial Stewardship through the U.S. Food and Drug Administration Prescription Drug User Fee Act (PDUFA). Statement of the IDSA befor the House Committee on Energy and Commerce’s Subcommittee on Health‌
    Kallen A, Mu Y, Bulens S, Reingold A, et al.‌ Healthcare-Associated Invasive MRSA Infections, 2005-2008‌
    Centers for Disease Control and Preventino‌ Types of Healthcare-Associated Infections‌
    Mauldin P, Salgado C, Hansen I, Durup D, et al.‌ Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic Resistant Gram-Negative Bacteria‌
    Rboerts R, Hota B, Ahmad I, Scott R, et al.‌ Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implicatons for antibiotic stewardship‌
    Vincent J, Rello J, Marshall J, Silva E, et al‌ International Study of the Prevalence and Outcomes of Infection in Intensive Care Units‌
    Redelings M, Sorvillo F, Mascola L‌ Increase in Clostridium Difficile-Related Mortality Rates, 1999 -2004‌
    Laximinaryan R, Malani A, Howard D, Smith D‌ Extending the Cure: Policy responses to the growing threat of antibiotic resistance‌
    Hersh A, Newland J, Beekmann S, Polgreen P, et al.‌ Unmet Medical Need in Infectious Diseases‌
    Ebnother C, Tanner B, Schmid F, La Rocca V, et al.‌ Impact of an Infection Control Program on the Prevalence of Nonsocomial Infections at a Tertiary Care Center in Switzerland‌
    Agency for Healthcare Research and Quality‌ Preventing Healthcare-Associated Infections: Initiating promising solutions and expanding proven ones: Commentaries by AHRQ Director, Dr. Carolyn Clancy, and other staff members‌
    Frieden T, Khabbaz R‌ A CDC Framework for Preventing Infectious Diseases: Sustaining the essentials and innovating for the future‌
    Standiford H, Chan S, Tripoli M, Weekes E, et al‌ Antimicrobial Stewardship at a Large Tertiary Care Academic Medical Center: Cost analysis, before, during, and after a 7-year program‌
    Frieden T‌ Antibiotic Resistance and the Threat to Public Health: Statement of Thomas Friden, MD, MPH, Director of the CDC: before the Committee on Energy and Commerce Subcommittee on Health, U.S. House of Representatives‌
    Silber J, Rosenbaum P, Trudeau M, Chen W, et al‌ Preoperative Antibiotics and Mortality in the Elderly‌
    Centers for Disease Control and Prevention‌ The State of Vision, Aging, and Public Health in America‌
    Saaddine J, Honeycutt A, Narayan V, Zhang X, et al‌ Projection of Diabetic Retinopathy and Other Major Eye Diseases Among People with Diabetes Mellitus: United States 2005-2050‌
    National Center for Health Statistics‌ National Health Interview Survey, 2011‌
    Kerr G, Worringham C, Cole M, Lacherez P, et al.‌ Predictors of Future Falls in Parkinson Disease‌
    Parkinson's Disease Foundation‌ Dollar Cost of Parkinson’s Underscores Need for Research‌
    Parkinson's Disease Foundation‌ Statistics on Parkinson’s‌
    National Parkinson Foundation‌ Parkinson’s Disease Overview‌
    National Alliance for Caregiving‌ Caregiving Costs: Declining Health in the Alzheimer’s Caregiver as Dementia Increases in the Care Recipient‌
    Alzheimer's Association‌ 2009 Alzheimer’s Disease Facts and Figures‌
    Alzheimer's Association‌ 2013 Alzheimer’s Disease Facts and Figures‌
    Fraze T, Jiang J, Burgess J‌ Hospital Stays for Patients with Diabetes‌
    Huang E, Basu A, O'Grady M, Capretta J‌ Projecting the Future Diabetes Population Size and Related Costs for the U.S.‌
    Centers for Disease Control and Prevention‌ National Diabetes Fact Sheet, 2011‌
    Go A, Mozaffarian D, Roger V, Benjamin E, et al.‌ Executive Summary: Heart disease and stroke statistics—2014 update‌
    Hall M, Levant S, DeFrances C‌ Hospitalizations for Stroke in U.S. Hospitals, 1989-2009‌
    Kochanek K, Xu J, Murphy S, Minino A, et al.‌ Deaths: Final data for 2009‌
    Heidenreich P, Trogdon J, Khaviou O, Butler J, et al.‌ Forecasting the Future of Cardiovascular Disease in the United States: A policy statement from the American Heart Association‌
    Go A, Mozaffarian D, Roger V, Benjamin E, et al.‌ Heart Disease and Stroke Statistics– 2013 Update‌
    Mariotto A, Yarbroff K, Shao Y, Feuer E, et al.‌ Projections of the Cost of Cancer Care in the United States: 2010-2020‌
    Fitch K, Pyenson B‌ Cancer Patients Receiving Chemotherapy: Opportunities for better management‌
    Centers for Disease Control and Prevention‌ FastStats: Cancer‌
    National Center for Health Statistics‌ National Ambulatory Medical Care Survey: 2010 Summary Tables, Table 13‌
    Tang D, Alberts D, Nevins R, Sullivan S, et al‌ Hospitalizations, and Productivity Associated with Cancer in U.S. Employer Settings‌
    Mitchell A, Ferguson D, Gill J, Paul J, et al.‌ Depression and Anxiety in Long-Term Cancer Survivors Compared with Spouses and Healthy Controls: A systematic review and meta-analysis‌
    American Cancer Society‌ Cancer Facts & Figures 2013‌
    Smith B, Smith G, Hurria A, Hortobagyi G, et al‌ Future of Cancer Incidence in the United States: Burdens upon an aging, changing nation‌
    Veghte B‌ Health Care Consumes Over a Third of Social Security‌
    Centers for Disease Control and Prevention‌ Chronic Diseases the Power to Prevent, The Call to Control: At a glance 2009.‌
    Centers for Disease Control and Prevention‌ Healthy Aging, Helping People to Live Long and Productive Lives and Enjoy a Good Quality of Life: At a glance 2011‌
    Freid V, Bernstein A, Bush M‌ Multiple Chronic Conditions among Adults Aged 45 and Over: Trends over the past 10 years‌
    Hoyert D, Xu J‌ Deaths: Preliminary Data for 2011‌
    Gorina Y, Kelly T, Lubitz J, Hines Z‌ Trends in Influenza and Pneumonia Among Older Persons in the United States‌
    Brenzel L, Wolfson L, Fox-Rushby J, Miller M, et al.‌ Vaccine-Preventable Diseases In: Disease control priorities in developing countries (second edition)‌
    Nichol K, D'Heilly S, Greenberg M, Ehlinger E, et al.‌ Burden of Influenza-like Illness and Effectiveness of Influenza Vaccination Among Working Adults Aged 50-64 Years‌
    Rothberg M, Virapongse A, Smith K‌ Cost-Effectiveness of a Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults‌
    Centers for Disease Control and Prevention‌ Advisory Committee on Immunization Practices: Record of the proceedings‌
    Pellesier J, Brisson M, Levin M‌ Evaluation of the Cost-Effectiveness in the United States of a Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults‌
    Prosser L, Lavelle T, Fiore A, Bridges C, et al‌ Cost-Effectiveness of 2009 Pandemic Influenza A (H1N1) Vaccination in the United States‌
    Molinari N, Ortega-Sanchez I, Messonnier M, Thompson W, et al.‌ The Annual Impact of Seasonal Influenza in the U.S.: Measuring disease burden and costs‌
    Pearson M, Bridges C, Harper S‌ Influenza Vaccination of Health-Care Personnel‌
    Nichol K‌ Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza‌
    Smith K, Nowalk M, Raymund M, Zimmerman R‌ Cost-Effectiveness of Pneumococcal Conjugate Vaccination in Immunocompromised Adults‌
    Weycker D, Sato R, Strutton D, Edelsberg J, et al‌ Public Health and Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine in U.S. Adults Aged > 50 Years‌
    Barrett S‌ Eradication Versus Control: The economics of global infectious disease policies‌
    Bloom D, Canning D, Weston M‌ The Value of Vaccination‌
    Ehreth J‌ The Global Value of Vaccination‌
    Institute of Medicine‌ America’s Vital Interest in Global Health: Protecting our people, enhancing our economy, and advancing our international interests‌
    Rappaport R‌ CDC: Immunizations high but a shot in the arm still needed‌
    Oxman M, Levin M, Johnson G, Schmader K, et al.‌ A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults‌
    Mahamud A, Marin M, Nickell S, Shoemaker T, et al.‌ Herpes Zoster-Related Deaths in the United States: Validity of death certificates and mortality rates, 1979-2007‌
    Macioesk M, Solberg L, Coffield A, Edwards N, et al.‌ Influenza Vaccination: Health impact and cost effectiveness among adults aged 50 to 64 and 65 and older‌
    Centers for Disease Control and Prevention‌ Influenza Vaccination of Health-Care Personnel‌
    Salgado C, Giannetta E, Hayden F, Farr B‌ Preventing Nosocomial Influenza by Improving the Vaccine Acceptance Rate of Clinicians‌
    Nichol K, Lind A, Karen K, Murdoch M, et al.‌ The Effectiveness of Vaccination Against Influenza in Healthy, Working Adults‌
    Centers for Disease Control and Prevention‌ Vaccine Effectiveness: How well does the flu vaccine work?‌
    Kostova D, Reed C, Finelli L, Cheng P, et al.‌ Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011‌
    Whitney C, Farley M, Hadler J, Harrison L, et al‌ Decline in Invasive Pneumococcal Disease After the Introduction of Protein-Polysaccharide Conjugate Vaccine‌
    Immunization Action Coalition‌ Ask the Experts: Pneumococcal vaccines‌
    Birmingham, M. and C. Stein.‌ The Burden of Vaccine-Preventable Diseases. In The Vaccine Book‌
    Patel M, Gebremariaum A, Davis M‌ Herpes Zoster-Related Hospitalizations and Expenditures Before and After Introduction of the Varicella Vaccine in the United States‌
    Dworkin R, White R, O'Connor A, Hawkins K‌ Health Care Expenditure Burden of Persisting Herpes Zoster Pain‌
    Thomas C, Ryan M, Chapman J, Stason W, et al‌ Incidence and Cost of Pneumonia in Medicare Beneficiaries‌
    Insinga R, Itzler R, Pellissier J, Saddier P, et al.‌ The Incidence of Herpes Zoster in a United States Administrative Database‌
    Thompson W, Shay D, Weintraub E, Brammer L, et al‌ Mortality Associated with Influenza and Respiratory Synctial Virus in the United States‌
    Centers for Disease Control and Prevention‌ Estimates of Deaths Associated with Seasonal Influenza: United States, 1976-2007‌
    National Center for Health Statistics‌ Current Estimates from the National Health Interview Survey, 1995‌
    Laessig K‌ End Points in Hospital-Acquired Pneumonia and/or Ventilator-Associated Pneumonia Clinical Trials: Food and Drug Administration perspective‌
    Mortensen E, Kapoor W, Chang C, Fine M‌ Assessment of Mortality After Long-Term Follow-Up of Patients with Community-Acquired Pneumonia‌
    National Center for Health Statistics‌ Deaths: Final data for 2010‌
    Martson B, Plouffe J, File T, Hackman B, et al.‌ Incidence of Community-Acquired Pneumonia Requiring Hospitalization‌
    Lin F, Hadler J‌ Epidemiology of Primary Varcilla and Herpes Zoster Hospitalizations: The pre-varicella vaccine era‌
    Schmader K‌ Herpes Zoster in Older Adults‌
    Kaplan V, Angus D, Griffin M, Clermont G, et al.‌ Hospitalized Community-Acquired Pneumonia in the Elderly‌
    Jackson M, Neuzil K, Thompson W, Shay D, et al.‌ The Burden of Community-Acquired Pneumonia in Seniors: Results of a population-based study‌
    Harpaz R, Ortega-Sanchez I, Seward J‌ Prevention of Herpes Zoster: Recommendations of the advisory committee on immunization practices (ACIP)‌
    Centers for Disease Control and Prevention‌ Seasonal Influenza‌
    National Center for Health Statistics‌ 2004 National Nursing Home Survey, Residents, table 33D‌
    McEachern R, Campbell G‌ Hospital-Acquired Pneumonia: Epidemiology, etiology, and treatment‌
    Niederman M, Mandell L, Anzueto A, Bass J, et al.‌ Guidelines for the Management of Adults with Community-Acquired Pneumonia‌
    Centers for Disease Control and Prevention‌ Herpes Zoster Vaccination Information for Health Care Professionals‌
    National Institute of Allergy and Infectious Diseases‌ Report of the Task Force on Microbiology and Infectious Disease‌
    National Institute of Allergy and Infectious Diseases‌ NIAID: Planning for the 21st Century‌
    Reid K, Grizzard T, Poland G‌ Adult Immunizations: Recommendations for practice‌
    Centers for Disease Control and Prevention ‌ CDC Influenza Update for Geriatricians and Other Clinicians Caring for People 65 and Older‌
    National Osteoporosis Foundation‌ The 2010 Burden of Osteoporosis and Low Bone Mass among Residents of the U.S. Age 50 and Older‌
    Wolf P, Abbott R, Kannell W‌ Atrial Fibrillation as an Independent Risk Factor for Stroke: The Framingham Study‌
    Johnson S, Diener M, Kaltenboeck A, Binbaum H, et al.‌ An Economic Model of Parkinson’s Disease: Implications for slowing progression in the United States‌
    Kowal S, Dall T, Chakrabarti R, Storm M, et al.‌ The Current and Projected Economic Burden of Parkinson’s Disease in the United States‌
    Tsang A, von Korff M, Lee S, et al‌ Common Chronic Pain Conditions in Developed and Devloping Countries: Gender and age differences and comorbidity with depression-anxiety disorders‌
    Institute of Medicine; Committee on Advancing Pain Research, Care and Education‌ Relieving Pain in America: A blueprint for transforming prevention, care, education, and research‌
    Johannes C, Le T, Zhou X, Dworkin R‌ The Prevalence of Chronic Pain in United States Adults: Results of an Internet-based survey‌
    Centers for Disease Control and Prevention, National Center for Health Statistics‌ Health, United States, 2006: With chartbook on trends in the health of Americans‌
    Croft P, Blyth F, Van der Windt D‌ The Global Occurrence of Chronic Pain: An Introduction. In Chronic Pain Epidemiology: From aetiology to public health‌
    Apfelbaum J, Chen C, Mehta S, Gan T, et al‌ Postoperative Pain Experience: Results from a national survey suggest postoperative pain continues to be undermanaged‌
    National Institute of Arthritis and Musculoskeletal and Skin Diseases‌ Arthritis‌
    Ferrell B, Ferrell B, Rivera L‌ Pain in Cognitively Impaired Nursing Home Patients‌
    Agency for Healthcare Research and Quality‌ Shingles Sends Nearly 1 Million Americans to the Doctor‌
    Green C, Hart-Johnson T, Loeffler D‌ Cancer-Related Chronic Pain: Examining quality of life in diverse cancer survivors‌
    Wolfe F, Ross K, Anderson J, Russell I, et al‌ The Prevalence and Characteristics of Fibromyalgia in the General Population‌
    National Center for Health Statistics‌ Health: United States, 2010: With special feature on death and dying‌
    Connors A, Dawson N, Desbiens N, Fulkerson W, et al.‌ A Controlled Trial to Improve Care for Seriously Ill Hospitalized Patients: The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT)‌
    Thomas E‌ Pain in Older People‌
    Teno J, Weitzen S, Wetle T, Mor V‌ Persistent Pain in Nursing Home Residents‌
    Hall M, DeFrances C, Williams S, Golosinskiy A, et al.‌ National Hospital Discharge Survey: 2007 Summary‌
    Centers for Disease Control and Prevention‌ Shingles: Overview‌
    Centers for Disease Control and Prevention‌ Morbidity and Mortality Weekly Report: Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation-United States, 2007-2009‌
    Krueger A, Stone A‌ Assessment of Pain: A community-based diary survey in the USA‌
    Becker N, Bondegaard Thomsen A, Olsen A, et al‌ Pain Epidemiology and Health Related Quality of Life in Chronic Non-Malignant Pain Patients Referred to a Danish Multidisciplinary Pain Center‌
    Gallup Organization‌ Pain in America: A Research report‌
    Ferrell B‌ Pain Evaluation and Management in the Nursing Home‌
    National Institute of Neurological Disorders and Stroke‌ Low Back Pain Fact Sheet‌
    Research!America‌ Americans Talk About Pain: A survey among adults nationwide‌
    Ortho-McNeil Pharmaceutical‌ Pain and Absenteeism in the Workplace‌
    Stewart W, Ricci J, Chee E, Morganstein D, et al‌ Lost Productive Time and Cost Due to Common Pain Conditions in the U.S. Workforce‌
    National Sleep Foundation‌ Sleep in America Poll‌
    Centers for Disease Control and Prevention, National Center for Health Statistics‌ Health, United States, 2007: with chartbook on trends in the health of Americans‌
    Okifuji A, Turk D, Curran S‌ Anger in Chronic Pain: Investigations of anger targets and intensity‌
    Hitchcock L, Ferrell B, McCaffery M‌ The Experience of Chronic Nonmalignant Pain‌
    Tang N, Crane C‌ Suicidality in Chronic Pain: A review of the prevalence, risk factors, and psychological links‌
    Illgen M, Zivin K, McCammon R, Valenstein M‌ Pain and Suicidal Thoughts, Plans, and Attempts in the United States‌
    Gaskin D, Richard P‌ The Economic Costs of Pain in the United States‌
    Cousins M, Power I, Smith G‌ 1996 Labat Lecture: Pain–A persistent problem‌
    Thorpe K, Florence C, Joski P‌ Which Medical Conditions Account for the Rise in Health Care Spending?‌
    Stewart S, MacIntyre K, Hole D, Capewell S, et al ‌ More ‘Malignant’ than Cancer? Five-year survival following a first admission for heart failure‌
    Schofield D, Kelly S, Shrestha R, Callander E, et al‌ The Impact of Back Problems on Retirement Wealth‌
    Sinnott P, Wagner T‌ Low Back Pain in VA Users: Letter to the editor‌
    Duehmke R, Derry S, Wiffen P, Bell R, et al.‌ Tramadol for Treating Neuropathic Pain‌
    Moore R, Wiffen P, Derry S, McQuay H‌ Gabapentin for Chronic Neuropathic Pain and Fibromyalgia in Adults‌
    Cardenas D, Nieshoff E, Suda K, Goto S, et al.‌ A Randomized Trial of Pregabalin in Patients with Neuropathic Pain due to Spinal Cord Injury‌
    Derry S, Lloyd R, Moore R, McQuay H‌ Topical Capsaicin for Chronic Neuropathic Pain in Adults‌
    Derry S, Moore R, Rabbie R‌ Topical NSAIDs for Chronic Musculoskeletal Pain in Adults‌
    Katz N, Borenstein D, Birbara C, Bramson C, et al.‌ Efficacy and Safety of Tanezumab in the Treatment of Chronic Low Back Pain‌
    Lunn M, Hughes R, Wiffen P‌ Duloxetine for Treating Painful Neuropathy or Chronic Pain‌
    Hoffman B, Papas R, Chatkoff D, Kerns R‌ Meta-Analysis of Psychological Interventions for Chronic Low Back Pain‌
    Kerns R, Kassirer M, Otis J‌ Pain in Multiple Sclerosis: A biopsychosocial perspective‌
    Fransen M, McConnell S‌ Land-Based Exercise for Osteoarthritis of the Knee: A meta-analysis of randomized controlled trials‌
    Kanodia A, Legedza A, Davis R, Eisenberg D, et al.‌ Perceived Benefit of Complementary and Alternative Medicine (CAM) for Back Pain: A national survey‌
    Witt C, Jena S, Selim D, Brinkhaus B, et al‌ Pragmatic Randomized Trial Evaluating the Clinical and Economic Effectiveness of Acupuncture for Chronic Low Back Pain‌
    Papaleontiou M, Henderson C, Turner B, Moore A, et al.‌ Outcomes Associated with Opioid Use in the Treatmetn of Chronic Noncacner Pain in Older Adults: A systematic reveiw and meta-analysis‌
    Dellapina E, Ory- Magne F, Regragui W, Thalamas C, et al.‌ Effect of Subthalamic Deep Brain Stimulation in Parkinson’s Disease‌
    Toth C, Mawani S, Brady S, Chan C, et al‌ An Enriched-Enrollment, Randomized Withdrawal, Flexible-Dose, Double-Blind, Placebo-Controlled, Parallel Assignment Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain‌
    Campbell C, Kipnes M, Stouch B, Brady K, et al.‌ Randomized Control Trial of Topical Clonidine for Treatment of Painful Diabetic Neuropathy‌
    Cuatrecasas G, Alegre C, Fernandez-Sola J, Gonzalez M, et al.‌ Growth Hormone Treatment for Sustained Pain Reduction and Improvement in Quality of Life in Severe Fibromyalgia‌
    Russell J, Holman A, Swick T, Alvarez-Horine S, et al‌ Sodium Oxybate Reduces Pain, Fatigue, and Sleep Disturbance and Improves Functionality in Fibromyalgia: Results from a 14-week randomized, double-blind, placebo-controlled study‌
    Oldenmenger W, Sillevis Smitt P, van Montfort C, de Raaf P, et al.‌ A Combined Pain Consultation and Pain Education Program Decreases Average and Current Pain and Decreases Interference in Daily Life by Pain in Oncology Outpatients: A randomized controlled trial‌
    Mayo Clinic‌ Pain Rehabilitation Center in Minnesota: Treatment outcomes‌
    Lind B, Lafferty W, Tyree P, Diehr P‌ Comparison of Health Care Expenditures Among Insured Users and Nonusers of Complementary and Alternative Medicine in Washington State: A cost minimization analysis‌
    Xu Z, Zhang L, Liu T, Park J, et al‌ Resolvins RvE1 and RvD1 Attenuate Inflammatory Pain Via Central and Peripheral Actions‌
    Watson J, Allen S, Dawbarn D‌ Targeting New Growth Factor in Pain: What is the therapeutic potential?‌
    Woolf C‌ Overcoming Obstacles to Developing New Analgesics‌
    Duan K, Xu Q, Zhang X, Zhao Z, et al.‌ Targeting A-Type K+ Channels in Primary Sensory Neurons for Bone Cancer Pain in a Rat Model‌
    Ahmed A, Li J, Erlandsson-Harris H, Stark A, et al‌ Suppression of Pain and Joint Destruction by Inhibition of the Proteasome System in Experimental Osteoarthritis‌
    Shi X, Lim T, Lee S, Zhao Y, et al‌ Statins Alleviate Experimental Nerve-Injury Induced Neuropathic Pain‌
    Apkarian V‌ The Brain in Chronic Pain: Clinical implications‌
    Prevent Blindness America‌ Vision Problems in the U.S.: Prevalence of adult vision impairment and age-related eye disease in the U.S.‌
    Ford E, Ajani U, Croft J, Critchely J, et al.‌ Explaining the Decrease in US Deaths from Coronary Disease, 1980-2000‌
    Medical Expenditures Panel Survey of the Agency for Healthcare Research and Quality‌ Total Expenses and Percent Distribution for Selected Conditions by Source of Payment, United States‌
    Centers for Medicare and Medicaid Services‌ Health Care Financing Review: Medicare & Medicaid Statistical Supplement‌
    Johnston S, Fayad P, Gorelick P, Hanley D, et al.‌ Prevalence and Knowledge of Transient Ischemic Attacks Among US Adults‌
    Russo C, Andrews R‌ The National Hospital Bill: The most expensive conditions, by Payer, 2004: HCUP Statistical Brief No. 13‌
    Russo C, Ho K, Elixhauser A‌ Hospital Stays for Circulatory Diseases, 2004‌
    Lakshimarayan K, Solid C, Collins A, Anderson D, et al.‌ Atrial Fibrillation and Stroke in the General Medicare Population: A 10-year prospective‌
    Elixhauser A, Owens P‌ Reasons for Being Admitted to the Hospital Through the Emergency Department. HCUP Statistical Brief No. 13‌
    Centers for Disease Control and Prevention‌ Vital Statistics Public Use Files–2008 Mortality Multiple Causes Files‌
    National Institutes of Health‌ Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases‌
    Roger V, Go A, Lloyd-Jones D, Benjamin E, et al.‌ Heart Disease and Stroke Statistics–2012 Update‌
    Alzheimer's Association‌ 2012 Alzheimer’s Disease Facts and Figures‌
    Newcomer L‌ Changing Physician Incentives For Cancer Care To Reward Better Patient Outcomes Instead Of Use Of More Costly Drugs‌
    Pysenson B, Sander M, Jiang Y, Kahn H, et al‌ An Actuarial Analysis Shows That Offering Lung Cancer Screening As An Insurance Benefit Would Save Lives At Relatively Low Cost‌
    Mirkin J, Lowrance W, Feifer A, Mulhall J, et al.‌ Direct-To-Consumer Internet Promotion Of Robotic Prostatectomy Exhibits Varying Quality Of Information‌
    Jacobs B, Zhang Y, Skolarus T, Hollenbeck B‌ Growth Of High-Cost Intensity-Modulated Radiotherapy For Prostate Cancer Raises Concerns About Overuse‌
    Ubel P, Berry S, Nadler E, Bell C, et al‌ In a Survey, Marked Inconsistency in How Oncologists Judged Value of High-Cost Cancer Drugs in Relation to Gains in Survival‌
    Neumann P, Bliss S, Chambers J‌ Therapies For Advanced Cancers Pose A Special Challenge For Health Technology Assessment Organizations In Many Countries‌
    Romley J, Sanchez Y, Penrod J, Goldman D, et al.‌ Survey Results Show that Adults are Willing to Pay Higher Insurance Premiums for Generous Coverage of Specialty Drugs‌
    Phillipson T, Eber M, Lakdawalla D, Corral M, et al.‌ An Analysis Of Whether Higher Health Care Spending In The United States Versus Europe Is ‘Worth It’ In The Case of Cancer‌
    Administration on Aging‌ A Profile of Older Americans: 2011‌
    Bearse M, Adams A, Han Y, Schneck M, et al‌ A Mulifocal Electroretinogram Model Predicting the Development of Diabetic Retinopathy‌
    Javitt J, Aiello L, Chiang Y, Greenfield S‌ Preventive Eye Care in People With Diabetes is Cost-Saving to the Federal Government: Implications for health care reform‌
    Ramirez M, Wu Z, Moreno-Carranza B, Jeziorski M, et al‌ Vasoinhibin Gene Transfer by Adenoassociated Virus Type 2 Products Against VEGF-and Diabetes-Induced Retinal Vasopermeability‌
    Bressler N, Bressler S, Congdon N, Ferris F, et al.‌ Potential Public Health Impact of Age-Related Eye Disease Study Results: AREDS report no. 11‌
    Guymer R, Tao L, Goh J, Liew D, et al.‌ Identification of Urine Biomarkers for AMD‌
    Gin T, Luu C, Guymer R‌ Central Retinal Function as Measured by the Multifocal Electroretinogram and Flicker Perimetry in AMD‌
    Rein D, Wittenborn J, Zhang X, Honeycutt A, et al‌ Forecasting Age-Related Macular Degeneration Through the Year 2050‌
    Bressler N, Doan Q, Varma R, Lee P, et al‌ Estimated Cases of Legal Blindness and Visual Impairment Avoided Using Ranibizumab for Choroidal Neovascularization: Non-Hispanic white population in the United States with age-related macular degeneration‌
    Lighthouse International‌ Diabetic Retinopathy Treatment and Care‌
    Aptel F, Charrell T, Lafon C, Ramano F, et al‌ Miniaturized High-Intensity Focused Ultrasound Device in Patients with Glaucoma: A clinical pilot study‌
    National Eye Institute‌ Facts About Diabetic Retinopathy‌
    National Institutes of Health, National Eye Institute‌ Early Treatment Diabetic Retinopathy Study‌
    Tapp R, Shaw J, Harper C, P de Courten M, et al‌ The Prevalence of and Factors Associated with Diabetic Retinopathy in the Australian Population‌
    Seddon J, Ajani U, Sperduto R, Hiller R, et al‌ Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration‌
    Mares J, Voland R, Sondel S, Millen A, et al.‌ Healthy Lifestyles Related to Subsequent Prevalence of Age-Related Macular Degeneration‌
    Rosenfeld P, Brown D, Heier J, Boyer D, et al‌ Ranibizumab for Neovascular Age-Related Macular Degeneration‌
    Patel J, Chen F, Da Cruz L, Rubin G, et al.‌ Contrast Sensitivity Outcomes in the ABC Trial: A randomized trial of bevacizumab for neovascular age-related macular degeneration‌
    Weigert G, Kay S, Pemp B, Sacu S, et al.‌ Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients with Age-Related Macular Degeneration‌
    Zhang K, Hopkins J, Heier J, Birch D, et al‌ Ciliary Neurotrophic Factor Delievered by Encapsulated Cell Intraocular Implants for Treatment of Geographic Atrophy in Age-Related Macular Degeneration‌
    Christen W, Glynn R, Chew E, Albert C, et al.‌ Folic Acid, Pyridoxine, and Cyanocobalamin Combination Treatment and Age-Related Macular Degeneration in Women‌
    Klein R, Chou C, Klein B, Zhang X‌ Prevalence of Age-Related Macular Degeneration in the U.S. Population‌
    Connor K, SanGiovanni J, Lofqvist C, Aderman C, et al.‌ Increased Dietary Intake of Omega-3 Polyunsaturated Fatty Acids Reduces Pathological Retinal Angiogenesis‌
    Lam B, Zheng D, Davila E, Arheart K, et al.‌ Trends in Glaucoma Medication Expenditures‌
    Rein D, Zhang P, Wirth K, Lee P, et al‌ The Economic Burden of Major Adult Visual Disorders in the United States‌
    Day S, Acquah K, Lee P, Mruthyunjaya P, et al.‌ Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007‌
    Bramely T, Peeples P, Walt J, Juhasz M, et al.‌ Impact of Vision Loss on Costs and Outcomes in Medicare Beneficiaries with Glaucoma‌
    Friedman D, Wolfs R, O'Colmain B, Klein B, et al.‌ Prevalence of Open-Angle Glaucoma Among Adults in the United States‌
    Wood J, Lacherez P, Black A, Cole M, et al‌ Risk of Falls, Injurious Falls, and Other Injuries Resulting from Visual Impairment among Older Adults with Age-Related Macular Degeneration‌
    Soubrane G, Cruess A, Lotery A, Pauleikho D, et al‌ Burden and Health Care Resource Utilization in Neovascular Age-Related Macular Degeneration‌
    Brown M, Brown G, Sharma S, Kistler J, et al.‌ Utility Values Associated with Blindness in an Adult Population‌
    Centers for Disease Control and Prevention‌ Health, United States, 2009‌
    Prevent Blindness America‌ Vision Problems in the U.S. 2008: Prevalence of adult vision impairment and age-related eye disease in America‌
    Kertes P, Johnson M‌ Evidence-Based Eye Care‌
    National Institute of Arthritis and Musculoskeletal and Skin Diseases‌ Handout on Health: Osteoporosis‌
    Centers for Disease Control and Prevention, National Center for Chronic Disease and Health Promotion‌ National Diabetes Fact Sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011‌
    Kahn R‌ Reducing The Impact Of Diabetes: Is prevention feasible today, or should we aim for better treatment?‌
    Thorpe K‌ The Affordable Care Act Lays The Groundwork For A National Diabetes Prevention And Treatment Strategy‌
    Narayan K, Echouffo-Tcheugi J, Mohan V, Ali M‌ Global Prevention And Control Of Type 2 Diabetes Will Require Paradigm Shifts In Policies Within And Among Countries‌
    Spiegel A, Hawkins M‌ ‘Personalized Medicine’ To Identify Genetic Risks For Type 2 Diabetes And Focus Prevention: Can It Fulfill Its Promise?‌
    Villarivera C, Wolcott J, Jain A, Zhang Y, et al‌ The US Preventive Services Task Force Should Consider A Broader Evidence Base In Updating Its Diabetes Screening Guidelines‌
    National Committee for Quality Assurance‌ The State of Healthcare Quality Report, 2004‌
    Fletcher J, Richards M‌ Diabetes’s ‘Health Shock’ To Schooling and Earnings: Increased dropout rates and lower wages and employment in young adults‌
    Vojta D, De Sa J, Prospect T, Stevens S‌ Effective Interventions for Stemming the Growing Crisis Of Diabetes And Prediabetes: A national payer’s perspective‌
    Zhou X, Zhang P, Gregg E, Barker L, et al‌ A Nationwide Community-Based Lifestyle Program Could Delay or Prevent Type 2 Diabetes Cases and Save $5.7 Billion in 25 Years‌
    Fradkin J‌ Confronting the Urgent Challenge of Diabetes: An Overview‌
    He W, Muenchrath N‌ 90+ in the United States: 2006-2008‌
    Sean K, Sisko A, Truffer C, Poisal J, et al.‌ National Health Spending Projections Through 2020: Economic recovery and reform drive faster spending growth‌
    Administration on Aging‌ A Profile of Older Americans: 2010‌
    Genworth Financial‌ Genworth 2011 Cost of Care Survey: Home care providers, adulty day health care facilities, assisted living facilities and nursing homes‌
    Alzheimer's Association‌ 2011 Alzheimer’s Disease Facts and Figures‌
    Hebert L, Scherr P, Bienias J, Bennett D, et al.‌ Alzheimer Disease in the U.S. Population: Prevalence estimates using the 2000 census‌
    He W, Sengupta M, Velkoff V, DeBarros K‌ 65+ in the United States: 2005‌
    Hebert L, Beckett L, Scherr P, Evans D‌ Annual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 through 2050‌
    Plassman B, Langa K, Fisher G, et al‌ Prevalence of Dementia in the United States: The aging, demographics, and memory study‌
    PhRMA‌ 2009 Report: Medicines in development for heart disease and stroke‌
    Demaerschalk B, Yip T‌ Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United States‌
    Caro J‌ An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation‌
    Fagan S, Morgenstern L, Petitta A, Ward R, et al.‌ Cost-Effectiveness of Tissue Plasminogen Activator for Acute Ischemic Stroke‌
    Johnston S‌ The Economic Case for New Stroke Thrombolytics‌
    Gage B, Cardinalli A, Albers G, Owens D‌ Cost-Effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients with Nonvalvular Atrial Fibrillation‌
    Mercaldi C, Ciaramentaro M, Hahn B, Chalissery G‌ Cost Efficiency of Anticoagulation with Warfarin to Prevent Stroke in Medicare Beneficiaries with Nonvalvular Atrial Fibrillation‌
    Zimetbaum P, Reynolds M, Ho K, Gaziano T, et al‌ Impact of a Practice Guideline for Patients with Atrial Fibrillation on Medical Resource Utilization and Costs‌
    Eriksson B, Dahl O, Rosencher N, Kurth A, et al.‌ Dabigatran Etexilate Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Hip- Replacement: A randomised, double-blind, non-inferiority trial‌
    Fuji T, Fujita S, Kawai Y, Nakamura M, et al.‌ Efficacy and Safety of Edoxaban Verus Enoxaparin for the Prevention of Venous Thrombembolism Following Total Hip Arthroplasty: STARS J-V Trial‌
    Antithrombotic Trialists' Collaboration‌ Collaborative Meta-Analysis of Randomised Trials of Antiplatelet Therapy for Prevention of Death, Myocardial Infarction, and Stroke in High Risk Patients‌
    Hurlen M, Abdelnoor M, Smith P, Erikssen J, et al.‌ Warfarin, Aspirin, or Both After Myocardial Infarction‌
    ASPECT (Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis) Group‌ Effect of Long- Term Oral Anticoagulant Treatment on Mortality and Cardiovascular Morbidity After Myocardial Infarction‌
    Wilcox R, Bousser M, Betteridge J, Scernthaner G, et al‌ Effects of Pioglitazone in Patients with Type 2 Diabetes with or without Previous Stroke: Results from PROactive (PROspective pioglitAzone Clinical Trial in macro Vascular Events 04)‌
    Rashid, P, J Leonardi-Bee, and P Bath‌ Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events‌
    Furie K, Kasner S, Adams R, Albers G‌ Guidelines for the Prevention of Stroke in Patients with Stroke or Transient Ischemic Attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association‌
    Schnabel R, Sullivan L, Levy D, Pencina M, et al‌ Development of a Risk Score for Atrial Fibrillation (Framingham Heart Study): A community-based cohort study‌
    Day J, Crandall B, Osborn J, Weiss J, et al.‌ Atrial Fibrillation Ablation Significantly Reduces Long-Term Mortality and Strokes in a Large Patient Population‌
    Hart R, Pearce L, Aguilar M‌ Meta-Analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation‌
    Hart R, Benavente O, McBride R, Pearce L‌ Antithrombotic Therapy to Prevent Stroke in Patients with Atrial Fibrillation‌
    Brown D, Boden-Albala B, Langa K, Lisabeth L, et al.‌ Projected Costs of Ischemic Stroke in the United States‌
    Elkins J, Johnston S‌ Thirty-Year Projections for Deaths from Ischemic Stroke in the United States‌
    Heidenreich P, Trogdon J, Khavjou O, Butler J, et al.‌ Forecasting the Future of Cardiovascular Disease in the United States: A policy statement from the American Heart Association‌
    Deitelzweig S, Johnson B, Lin L, Schulman K‌ Prevalence of Clinical Venous Thromboembolism in the USA: Current trends and future projections‌
    Go A, Hylek E, Phillips K, Chang Y, et al.‌ Prevalence of Diagnosed Atrial Fibrillation in Adults: National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study‌
    Miyasaka Y, Barnes M, Gersh B, Cha S, et al.‌ Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence‌
    Damaerschalk B, Hwang H, Leung G‌ U.S. Cost Burden of Ischemic Stroke: A systematic literature review‌
    Leibson C, Hu T, Brown R, Hass S, et al.‌ Utilization of Acute Care Services in the Year Before and After First Stroke: A population-based study‌
    Taylor T, Davis P, Torner J, Holmes J, et al‌ Lifetime Cost of Stroke in the United States‌
    Roger V, Go A, Lloyd-Jones D, Adams R, et al.‌ Heart Disease and Stroke Statistics- 2011 Update‌
    Ollendorf D, Vera-Llonch M, Oster G‌ Cost of Venous Thromboembolism Following Major Orthopedic Surgery in Hospitalized Patients‌
    Wu E, Birnbaum H, Mareva M, Tuttle E, et al‌ Economic Burden and Co-Morbidities of Atrial Fibrillation in a Privately Insured Population‌
    Le Heuzey J, Paziaud O, Piot O, Ait S, et al.‌ Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study‌
    Sullivan E, Braithwaite S, Dietz K, Hickey C‌ Health Services Utilization and Medical Costs Among Medicare Atrial Fibrillation Patients‌
    Lee W, Lamas G, Balu S, Spalding J, et al.‌ Direct Treatment Cost of Atrial Fibrillation in the Elderly American Population: A Medicare perspective‌
    Schappert S, Rechsteiner E‌ Ambulatory Medical Care Utilization Estimates for 2007‌
    Fang J, Alderman M, Keenan N, Croft J‌ Declining U.S. Stroke Hospitalization Since 1997: National hospital discharge survey, 1998-2004‌
    Asplund, K, B Stegmayr, and M Peltonen‌ From the Twentieth to the Twenty- First Century: A public health perspective on stroke‌
    Rosenberg, CH and GM Popelka‌ Post-Stroke Rehabilitation: A review of the guidelines for patient management‌
    Centers for Disease Control and Prevention‌ Outpatient Rehabilitation Among Stroke Survivors: 21 states and the District of Columbia‌
    Kelly-Hayes M, Beiser A, Kase C, Scaramucci A, et al.‌ The Influence of Gender and Age on Disability Following Ischemic Stroke: The Framingham Study‌
    Centers for Disease Control and Prevention‌ Prevalence of Disabilities and Associated Health Conditions Among Adults: United States, 1999‌
    El-Saed A, Kuller L, Newman A, Lopez O, et al.‌ Geographic Variations in Stroke Incidence and Mortality Among Older Populations in Four U.S. Communities‌
    Centers for Disease Control and Prevention‌ Disparities in Deaths from Stroke Among Persons Aged <75 Years: United States, 2002‌
    Haake D, Berkman S‌ Venous Thromboembolic Disease after Hip Surgery: Risk factors, prophylaxis, and diagnosis‌
    Goldhaber S‌ Pulmonary Embolism‌
    Heit J‌ Venous Thromboembolism Epidemiology: Implications for prevention and management‌
    White R‌ The Epidemiology of Venous Thromboembolism‌
    Heit J, Fallon W, Petterson T, Lohse C, et al.‌ Relative Impact of Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A population-based study‌
    House of Commons Health Committee‌ The Prevention of Venous Thromboembolism in Hospitalised Patients: Second report of session 2004-05‌
    Anderson F, Wheeler B, Goldberg R, Hosmer D, et al‌ A Population-Based Perspective of the Hospital Incidence and Case-Fatality Rates of Deep Vein Thrombosis and Pulmonary Embolism: The Worcester DVT Study‌
    Heit J, Cohen A, Anderson Jr. F‌ Estimated Annual Number of Incident and Recurrent, Non-Fatal and Fatal Venous Thromboembolism (VTE) Events in the U.S.‌
    Thrall G, Lip G, Carroll D, Lane D‌ Depression, Anxiety, and Quality of Life in Patients with Atrial Fibrillation‌
    Kim M, Lin J, Hussein M, Battleman D‌ Incidence and Temporal Pattern of Hospital Readmissions for Patients with Atrial Fibrillation‌
    Wolf P, Mitchell J, Baker C, Kannel W, et al‌ Impact of Atrial Fibrillation on Mortality, Stroke, and Medical Costs‌
    Penado S, Cano M, Acha O, Hernandez J, et al.‌ Atrial Fibrillation as a Risk Factor for Stroke Recurrence‌
    Go A‌ The Epidemiology of Atrial Fibrillation in Elderly Persons: The tip of the iceberg‌
    Fuster V, Ryden L, Cannom D, Crijns H, et al.‌ ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation‌
    Centers for Disease Control and Prevention‌ Atrial Fibrillation as a Contributing Cause of Death and Medicare Hospitalization: United States 1999‌
    Miyasaka Y, Barnes M, Bailey K, Cha S, et al.‌ Mortality Trends in Patients Diagnosed with First Atrial Fibrillation: A 21-year community- based study‌
    Piccini J, Hammill B, Sinner M, Jensen P, et al.‌ Incidence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries from 1993 to 2007‌
    Casper M, Nwaise I, Croft J, Nilasena D‌ Atlas of Stroke Hospitalizations Among Medicare Beneficiaries‌
    National Heart, Lung, and Blood Institute‌ Incidence and Prevalence: 2006 chart book on cardiovascular and lung diseases‌
    Silverstein M, Heit J, Mohr D, Petterson T, et al‌ Trends in the Incidence of Deep Vein Thrombosis and Pulmonary Embolism: A 25- year population based study‌
    Lloyd-Jones D, Wang T, Leip E, Larson M, et al‌ Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study‌
    Genworth Financial‌ Genworth Finanical 2010 Cost of Care Survey: Home Care Providers, Adult Day Health Care Facilities, Assisted Living Facilities and Nursing Homes‌
    Federal Interagency Forum on Aging-Related Statistics‌ Older Americans 2010: Key Indicators of Well-Being‌
    Alzheimer's Association‌ Changing the Trajectory of Alzheimer’s Disease: How a treatment by 2025 saves lives and dollars‌
    Lloyd-Jones D, Adams R, Brown T, Carnethon M, et al‌ Heart Disease and Stroke Statistics- 2010 Update‌
    Rosenblum M, Kane M‌ Analysis of Cost and Utilization of Health Care Services Before and After Initiation of Insulin Therapy in Patients with Type 2 Diabetes Mellitus‌
    Cranor C, Bunting B, Christensen D‌ The Asheville Project: Long-Term Clinical and Economic Outcomes of a Community Pharmacy Diabetes Care Program‌
    Garret D, Bluml B‌ Patient Self-Management Program for Diabetes: First-year clinical, humanistic, and economic outcomes‌
    Ragucci K, Fermo J, Wessell A, Chumney E‌ Effectiveness of Pharmacist-Administered Diabetes Mellitus Education and Management Services‌
    Christensen N, Williams P, Pfister R‌ Cost Savings and Clinical Effectiveness of an Extension Service Diabetes Program‌
    Balamurugan A, Ohsfeldt R, Hughes T, Phillips M‌ Diabetes Self-management Education Program for Medicaid Recipients: A continuous quality improvement process‌
    Ackermann R, Marrero D, Hicks K, Hoerger T, et al‌ An Evaluation of Cost Sharing to Finance a Diet and Physical Activity Intervention to Prevent Diabetes‌
    Stockl K, Tjioe D, Gong S, et al‌ Effect of an Intervention to Increase Statin Use in Medicare Members Who Qualified for a Medication Therapy Management Program‌
    Sheils J, Rubin R, Stapleton D‌ The Estimated Costs and Savings of Medical Nutrition Therapy: The Medicare population‌
    Fera T, Bluml B, Ellis W‌ Diabetes Ten City Challenge: Final economic and clinical results‌
    Gaede P, Lund-Andersen H, Parving H, Pedersen O‌ Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes‌
    Straka R, Liu L, Girase P, Delorenzo A, et al‌ Incremental Cardiovascular Costs and Resource Use Associated with Diabetes: An assessment of 29,863 patients in the U.S. managed-care setting‌
    Xu J, Kochanek K, Tejada-Vera B‌ Deaths: Preliminary Data for 2007‌
    Shea A, Curtis L, Hammill B, Kowalski J, et al‌ Resource Use and Costs Associated with Diabetic Macular Edema in Elderly Persons‌
    Gilmer T, O'Connor P, Manning W, Rush W‌ The Cost to Health Plans of Poor Glycemic Control‌
    Dall T, Mann S, Zhang Y, Quick W, et al.‌ Distinguishing the Economic Costs Associated with Type 1 and Type 2 Diabetes‌
    Saczynski J, Siggurdsson S, Jonsson P, et al‌ Glycemic Status and Brain Injury in Older Individuals: The Age Gene/Environment Susceptibility–Reykjavik Study‌
    Schneider K, O'Donnell B, Dean D‌ Prevalence of Multiple Chronic Conditions in the United States’ Medicare Population‌
    Adler G‌ Diabetes in the Medicare Aged Population, 2004‌
    Crandall J, Knowler W, Kahn S, Marrero D, et al.‌ The Prevention of Type 2 Diabetes‌
    Alzheimer's Association‌ 2010 Alzheimer’s Disease Facts and Figures‌
    Thorpe K, Ogden L, Galactionova K‌ Chronic Conditions Account for Rise in Medicare Spending From 1987 to 2006‌
    Administration on Aging‌ A Profile of Older Americans: 2009‌
    Hartman M, Martin A, Nuccio O, Catlin A, et al.‌ Health Spending Growth at a Historic Low in 2008‌
    Olshansky S, Goldman D, Zheng Y, Rowe J‌ Aging in America in the Twenty-first Century: Demographic forecasts from the MacArthur Foundation Research Network on an Aging Society‌
    Huse D, Schulman K, Orsini L, Castelli-Haley J, et al.‌ Burden of Illness in Parkinson’s Disease‌
    Noyes K, Liu H, Li Y, Holloway R, et al.‌ Economic Burden Associated with Parkinson’s Disease on Elderly Medicare Beneficiaries‌
    Orsini L, Castelli-Haley J, Kennedy S, Huse D‌ Healthcare Utilization and Expenditures Among Privately Insured Patients with Parkinson’s Disease in the U.S.‌
    Whetten-Goldstein K, Sloan F, Kulas E, Cutson T, et al‌ The Burden of Parkinson’s Disease on Society, Family, and the Individual‌
    Leibson C, Long K, Maraganore D, Bower J, et al.‌ Direct Medical Costs Associated with Parkinson’s Disease: A population-based study‌
    Dowding C, Shenton C, Salek S‌ A Review of the Health-Related Quality of Life and Economic Impact of Parkinson’s Disease‌
    Hebert L, Scherr P, Bienias J, Bennett D‌ State-Specific Projections Through 2025 of Alzheimer Disease Prevalence‌
    MetLife Mature Market Institute‌ The MetLife Market Survey of Nursing Home and Assisted Living Costs‌
    Ravina B, Fagan S, Hart R, Hovinga C, et al‌ Neuroprotective Agents for Clinical Trials in Parkinson’s Disease: A systematic assessment‌
    Gradinaru V, Mogri M, Thompson K, Henderson J, et al.‌ Optical Deconstruction of Parkinsonian Neural Circuitry‌
    Fuentes R, Petersson P, Siesser W, Caron M, et al.‌ Spinal Cord Stimulation Restores Locomotion in Animal Models of Parkinson’s Disease‌
    Hoerger T, Bala M, Rowland C, Greer M, et al.‌ Cost Effectiveness of Pramipexole in Parkinson’s Disease in the U.S.‌
    Kurlan R, Clark S, Shoulson I, Penny J‌ Economic Impact of Protective Therapy for Early Parkinson’s Disease‌
    Weimer D, Sager M‌ Early Identification and Treatment of Alzheimer’s Disease: Social and fiscal outcomes‌
    Hill J, Futterman R, Mastey V, Fillit H‌ The Effect of Donepezil Therapy on Health Costs in a Medicare Managed Care Plan‌
    Parkinson Study Group‌ A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients with Parkinson Disease and Motor Fluctuations‌
    Rascol O, Brooks D, Korczyn A, De Deyn P, et al.‌ A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson’s Disease Who Were Treated with Ropinirole or Levodopa‌
    The Parkinson Study Group‌ Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease: A 4-year randomized controlled trial‌
    Dorsey E, Constantinescu R, Thompson J, Biglan K, et al.‌ Projected Number of People with Parkinson Disease in the Most Populous Nations, 2005 Through 2030‌
    Gage H, Hendricks A, Zhang S, Kazis L‌ The Relative Health Related Quality of Life of Veterans with Parkinsons Disease‌
    Fernandez H, Lapane K‌ Predictors of Mortality Among Nursing Home Residents with a Diagnosis of Parkinson’s Disease‌
    Melton L, Leibson C, Achenbach S, Bower J, et al.‌ Fracture Risk After the Diagnosis of Parkinson’s Disease: Influence of concomitant dementia‌
    Goetz C, Stebbins G‌ Risk Factors for Nursing Home Placement in Advanced Parkinson’s Disease‌
    Lieberman A‌ Depression in Parkinson’s Disease: A review‌
    Aarsland D, Andersen K, Larsen J, Lolk A‌ Prevalence and Characteristics of Dementia in Parkinson Disease: An 8-year prospective study‌
    Wood B, Bilclough J, Bowron A, Walker R‌ Incidence and Prediction of Falls in Parkinson’s Disease: A prospective multidisciplinary study‌
    Elbaz A, Bower J, Peterson B, Maraganore D, et al.‌ Survival Study of Parkinson Disease in Olmstead County, Minnesota‌
    Schulz R, Mendelsohn A, Haley W, et al‌ End-of-Life Care and the Effects of Bereavement on Family Caregivers of Persons with Dementia‌
    Medpac‌ Report to the Congress: Reforming the delivery system‌
    National Hospice and Palliative Care Organization‌ NHPCO Facts and Figures: Hospice Care in America‌
    Hyde J, Perez R, Forester B‌ Dementia and Assisted Living‌
    Maslow K‌ How Many Hospital Patients Have Dementia?‌
    Kalia M‌ Dysphagia and Aspiration Pneumonia in Patients with Alzheimer’s Disease‌
    Strickland D, Bertoni J‌ Parkinson’s Prevalence Estimated by a State Registry‌
    Van Den Eeden S, Tanner C, Bernstein A, Fross R, et al‌ Incidence of Parkinson’s Disease: Variation by age, gender, and race/ethnicity‌
    Elbaz A, Bower JH, Maraganore DM, et al‌ Risk Tables for Parkinsonism and Parkinson’s Disease‌
    National Parkinson Foundation‌ About Parkinson’s Disease‌
    Nussbaum R, Ellis C‌ Genomic Medicine: Alzheimer’s Disease and Parkinson’s Disease‌
    Russo C, Holmquist L, Elixhauser A‌ U.S. Hospitalizations Involving Osteoporosis and Injury, 2006‌
    Congressional Budget Office‌ High-Cost Medicare Beneficiaries‌
    O'Grady M, Capretta J‌ Health-Care Cost Projections for Diabetes and Other Chronic Diseases: The current context and potential enhancements‌
    American Cancer Society‌ Cancer Facts and Figures 2009‌
    Centers for Disease Control and Prevention ‌ Health, United States, 2008‌
    Centers for Medicare and Medicaid Services‌ National Health Expenditures: 2007 Highlights‌
    Lloyd-Jones D, Adams R, Carnethon M, De Simon G, et al.‌ Heart Disease and Stroke Statistics- 2009 Update‌
    Jones A‌ National Nursing Home Survey: 2004 current resident tables‌
    DeFrances C, Lucas C, Buie V, Golosinskiy A‌ 2006 National Hospital Discharge Survey‌
    Sisko A, Truffer C, Smith S, Keehan S, et al‌ Health Spending Projections Through 2018: Recession effects add uncertainty to the outlook‌
    American Cancer Society‌ Colorectal Cancer Facts & Figures, 2008-2010‌
    Cubanski J, Damico A, Neuman T‌ Health Care on a Budget: An analysis of spending by Medicare households‌
    Cowie C, Rust K, Ford E, Eberhardt M, et al.‌ Full Accounting of Diabetes and Pre-Diabetes in the U.S. Population in 1988-1994 and 2005-2006‌
    Paez K, Zhao L, Hwang W‌ Rising Out-Of-Pocket Spending For Chronic Conditions: A ten-year trend‌
    PhRMA‌ 2008 Report: Medicines in Development for Older Americans‌
    American Cancer Society‌ Cancer Facts & Figures 2008‌
    Deal C, Brown J, Recker R, Prince R, et al.‌ Direct Comparison of Changes in Bone Density and Bone Turnover Markers in Postmenopausal Women With Low Bone Mass Treated With 6-monthly Denosumab or Weekly Alendronate‌
    Alexander G, Sehgal N, Moloney R, Stafford R‌ National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007‌
    Thombs B, Bass E, Ford D, Stewart K, et al‌ Prevalence of Depression in Survivors of Acute Myocardial Infarction‌
    Lichtman J, Bigger J, Blumenthal J, Frasure-Smith N, et al.‌ Depression and Coronary Heart Disease: Recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association‌
    Beckett N, Peters R, Fletcher A, Staessen J, et al‌ Treatment of Hypertension in Patients 80 Years of Age or Older‌
    Setoguchi S, Glynn R, Avorn J, Mittleman M, et al‌ Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-year trend analysis‌
    Kaiser Family Foundation‌ Kaiser Fast Facts‌
    Goldman D, Cutler D, Shekelle P, Bhattacharya J, et al.‌ Modeling the Health and Medical Care Spending of the Future Elderly‌
    Research!America‌ Investment in Research Saves Lives and Money: Vision and Blindness‌
    U.S. Census Bureau‌ 2008 National Population Projections‌
    MacLean C, Newberry S, Maglione M, McMahon M, et al.‌ Systematic Review: Comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis‌
    National Committee for Quality Assurance‌ The State of Healthcare Quality Report 2007‌
    Centers for Disease Control and Prevention, National Center for Chronic Disease and Health Promotion‌ National Diabetes Fact Sheet, 2007‌
    Heron M, Hoyert D, Xu J, Scott C, et al.‌ Deaths: Preliminary data for 2006‌
    Grafe I, Da Fonseca K, Hilmeier J, Meeder P, et al.‌ Reduction of Pain and Fracture Incidence After Kyphoplasty: 1-year outcomes of a prospective controlled trial of patients with primary osteoporosis‌
    Mobley L, Hoerger T, Wittenborn J, Galuska D, et al.‌ Cost-Effectiveness of Osteoporosis Screening and Treatment with Hormone Replacement Therapy, Raloxifene, or Alendronate‌
    Fleurence R, Iglesias C, Johnson J‌ The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of Osteoporosis: A structured review of the literature‌
    Lasker Foundation‌ Exceptional Returns: The economic value of America’s investment in medical research‌
    National Institutes of Health‌ NIH Fact Sheet: Osteoporosis‌
    Ettinger B, Black D, Mitlak B, Knickerbocker R, et al.‌ Reduction of Vertebral Fracture Risk in Postmenopausal Women with Osteoporosis Treated with Raloxifene: Results from a 3-year randomized clinical trial‌
    Neer R, Arnaud C, Zanchetta J, Prince R, et al.‌ Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis‌
    Black D, Delmas P, Eastell R, et al‌ Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis‌
    Chestnut C, Skag A, Christiansen C, Recker R, et al.‌ Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis‌
    Harris S, Watts N, Genant H, McKeever C, et al.‌ Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women with Postmenopausal Osteoporosis: A randomized controlled trial‌
    Black D, Thompson D, Bauer D, et al‌ Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The fracture intervention trial‌
    Wagner E, Sandhu N, Newton K, McCulloch D, et al‌ Effect of Improved Glycemic Control on Health Care Costs and Utilization‌
    Papaioannou A, Watts N, Kendler D, Yuen C, et al.‌ Diagnosis and Management of Vertebral Fractures in Elderly Adults‌
    Chapuy M, Arlot M, Duboeuf F, Brun J, et al.‌ Vitamin D3 and Calcium to Prevent Hip Fractures in the Elderly Women‌
    Papadimitropoulos E, Wells G, Shea B, Gillespie W, et al.‌ VIII: Meta-analysis of the efficacy of vitamin d treatment in preventing osteoporosis in postmenopausal women‌
    Shea B, Wells G, Cranney A, Zytaruk N, et al‌ Meta-Analysis of Calcium Supplementation for the Prevention of Postmenopausal Osteoporosis‌
    Lindsay R, Pack S, Li Z‌ Longitudinal Progression of Fracture Prevalence through a Population of Postmenopausal Women with Osteoporosis‌
    Jaglal S, Weller I, Mamdani M, Hawker G, et al.‌ Population Trends in BMD Testing, Treatment, and Hip and Wrist Fracture Rates: Are the hip fracture projections wrong?‌
    Burge R, Dawson-Hughes B, Solomon D, Wong J, et al. ‌ Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005-2025‌
    U.S. Department of Health and Human Services‌ Bone Health and Osteoporosis: A report of the surgeon general‌
    National Osteoporosis Foundation‌ America’s Bone Health: The state of osteoporosis and low bone mass in our nation‌
    King A, Saag K, Burge R, Pisu M, et al.‌ Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment‌
    Braithwaite R, Col N, Wong J‌ Estimating Hip Fracture Morbidity, Mortality, and Costs‌
    Wehren L, Hawkes W, Orwig D, et al‌ Gender Differences in Mortality After Hip Fracture: The role of infection‌
    Miller P‌ Management of Osteoporosis‌
    Leibson C, Tosteson A, Gabriel S, Ransom J, et al.‌ Mortality, Disability, and Nursing Home Use for Persons with and without Hip Fracture: A population-based study‌
    Kado D, Browner W, Palermo L, Nevitt M, et al.‌ Vertebral Fractures and Mortality in Older Women: A prospective study‌
    Shekelle P, Ortiz E, Newberry S, Rich M, et al‌ Identifying Potential Health Care Innovations for the Elderly of the Future: Health and costs of the future elderly‌
    Tosteson A, Gabriel S, Grove M, Moncur M, et al‌ Impact of Hip and Vertebral Fractures on Quality-Adjusted Life Years‌
    Ross P, Davis J, Epstein R, Wasnich R‌ Pre-Existing Fractures and Bone Mass Predict Vertebral Fracture Incidence in Women‌
    Lindsay R, Silverman S, Cooper C, Hanley D, et al.‌ Risk of New Vertebral Fracture in the Year Following a Fracture‌
    Nevitt M, Ettinger B, Black D, Stone K, et al.‌ The Association of Radiographically Detected Vertebral Fractures with Back Pain and Function: A prospective study‌
    Hoerger T, Downs K, Lakshmanan M, Lindrooth R, et al.‌ Healthcare Use Among U.S. Women Aged 45 and Older: Total costs and costs selected postmenopausal health risks‌
    Salkeld G, Cameron I, Cumming R, Easter S, et al‌ Quality of Life Related to Fear of Falling and Hip Fracture in Older Women: A time trade off study‌
    Van Balen R, Essink-Bot M, Steyerberg E, Cools H, et al‌ Quality of Life After Hip Fracture: A comparison of four health status measures in 208 patients‌
    Marottoli R, Berkman L, Cooney Jr. L‌ Decline in Physical Function Following Hip Fracture‌
    Magaziner J, Fredman L, Hawkes W, Hebel J, et al.‌ Changes in Functional Status Attributable to Hip Fracture: A comparison of hip fracture patients to community-dwelling aged‌
    Kozak L, Owings M, Hall M‌ National Hospital Discharge Survey: 2001 annual summary with detailed diagnosis and procedure data‌
    Stafford R, Drieling R, Hersh A‌ National Trends in Osteoporosis Visits and Osteoporosis Treatment, 1988-2003‌
    National Osteoporosis Foundation‌ Clinician’s Guide to Prevention and Treatment of Osteoporosis‌
    Melton J‌ Who Has Osteoporosis? A conflict between clinical and public health perspectives‌
    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)‌ Handout on Health: Osteoporosis‌
    Stevens J, Hasbrouck L, Durant T, Dellinger A, et al‌ Surveillance for Injuries and Violence Among Older Adults‌
    Melton J‌ How Many Women Have Osteoporosis Now?‌
    Partnership to Fight Chronic Disease‌ Almanac of Chronic Disease: 2008 Edition‌
    Federal Interagency Forum on Aging-Related Statistics‌ Older Americans 2008: Key Indicators of Well-Being‌
    Alzheimer's Association‌ 2008 Alzheimer’s Disease Facts and Figures‌
    Yabroff R, Lamont E, Mariotto A, Warren J, et al‌ Cost of Care for Elderly Cancer Patients in the United States‌
    Gallup Healthways‌ Gallup Healthways Well-Being Index‌
    World Health Organization‌ World Health Statistics 2008‌
    Centers for Medicare and Medicaid Services‌ National Health Expenditure Projections 2007-2017‌
    Rosamond W, Flegal K, Furie K, Go A, et al‌ Heart Disease and Stroke Statistics- 2008 Update‌
    Keehan S, Sisko A, Truffer C, Smith S, et al.‌ Health Spending Projections Through 2017: The baby-boom generation is coming to medicare‌
    Centers for Medicare and Medicaid Services‌ National Health Expenditure Accounts: 2006 Highlights‌
    Administration on Aging‌ A Profile of Older Americans: 2007‌
    American Diabetes Association‌ Economic Costs of Diabetes in the U.S. in 2007‌
    Aaron C, Cowan C, Hartman M, Heffler S‌ National Health Spending In 2006: A year of change for prescription drugs‌
    Anderson G‌ Chronic Conditions: Making the case for ongoing care‌
    DeVol R, Bedroussian A, Charuworn A, Chatterjee A, et al.‌ An Unhealthy America: The economic burden of chronic disease‌
    Loeppke R, Taitel M, Richling D, Parry T, et al.‌ Health and Productivity as a Business Strategy‌
    Ford E, Ajani U, Croft J, Critchley J, et al.‌ Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980-2000‌
    Venkat Narayan K, Boyle J, Thompson T, Sorensen S, et al‌ Lifetime Risk for Diabetes Mellitus in the United States‌
    Espey D, Wu X, Swan J, Wiggins C, et al.‌ Annual Report to the Nation on the Status of Cancer, 1975-2004: Featuring cancer in American Indians and Alaska Natives‌
    Milken Institute‌ The Economic Burden of Chronic Disease on the United States‌
    Chiu C, Milton R, Gensler G, Taylor A‌ Association Between Dietary Glycemic Index and Age-Related Macular Degeneration in Nondiabetic Participants in the Age-Related Eye Disease Study‌
    Chiu C, Milon R, Klein R, Gensler G, et al.‌ Dietary Carbohydrate and the Progression of Age-Related Macular Degeneration: A prospective study from the Age-Related Eye Disease Study‌
    Kozma C, Lee P, Pitts J, Guiterrez P, et al.‌ Economic and Quality of Life Impact of Dry Eye Symptoms‌
    Moss S, Klein R, Klein B‌ Prevalence of and Risk Factors for Dry Eye Syndrome‌
    Schamberg D, ScheinOd G‌ Smolin and Thoft’s The Cornea: Scientific Foundations and Clinical Practice: 4th ed.‌
    Market Scope‌ Report on the Global Dry Eye Market‌
    Board of Trustees, Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds‌ 2007 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds‌
    Lee P, Walt J, Doyle J, Kotak S, et al.‌ A Multicenter, Retrospective Pilot Study of Resource Use and Costs Associated with Severity of Disease in Glaucoma‌
    Glaucoma Research Foundation‌ Glaucoma Facts and Stats‌
    Quigley H, Jampel H‌ How Are Glaucoma Patients Identified?‌
    Prevent Blindness America‌ The Economic Impact of Vision Problems: The toll of major adult eye disorders, visual impairment and blindness on the U.S. economy‌
    Javitt J, Aiello L‌ Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy‌
    Higginbotham E, Gordon M, Beiser J, Drake M, et al.‌ The Ocular Hypertension Treatment Study: Topical medication delays or prevents primary open-angle glaucoma in African American individuals‌
    Kass M, Heuer D, Higginbotham E, Johnson C, et al.‌ The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma‌
    Research to Prevent Blindness‌ Glaucoma‌
    Turner R, Holman R, Stratton I, Cull C, et al‌ Tight Blood Pressure Control and Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes‌
    Age-Related Eye Disease Study Research Group‌ A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS report no. 8‌
    Research to Prevent Blindness‌ Diabetic Retinopathy‌
    Gragoudas E, Adamis A, Cunningham E, Feinsod M, et al.‌ Pegaptanib for Neovascular Age-Related Macular Degeneration‌
    Kempen J, O'Colmain B, Leske M, et al‌ The Prevalence of Diabetic Retinopathy Among Adults in the United States‌
    Friedman D, O'Colmain B, Munoz B, Toma S‌ Prevalence of Age-Related Macular Degeneration in the United States‌
    Congdon N, O'Colmain B, Klaver C, Klein R, et al.‌ Causes and Prevalence of Visual Impairment Among Adults in the United States‌
    Eye Disease Prevalence Research Group‌ Blindness‌
    Javitt J, Zhou Z, Wilke R‌ Association Between Vision Loss and Higher Medical Care Costs in Medicare Beneficiaries: Costs are greater for those with progressive vision loss‌
    Frick K, Gower E, Kempen J, Wolff J‌ Economic Impact of Visual Impairment and Blindness in the United States‌
    AGIS Investigators‌ The Advanced Glaucoma Intervention Study, 8: Risk of cataract formation after trabeculectomy‌
    Haymes S, LeBlanc R, Nicolela M, Chiasson L, et al. ‌ Risk of Falls and Motor Vehicle Collisions in Glaucoma‌
    Mitchell J, Bradley C‌ Quality of Life in Age-Related Macular Degeneration: A review of the literature‌
    Wong T, Klein R, Sun C, Mitchell P, et al‌ Age-Related Macular Degeneration and Risk for Stroke‌
    Bass E, Marsh M, Mangione C, Bressler N, et al‌ Patients’ Perceptions of the Value of Current Vision: Assessment of preference values among patients with subfoveal choroidal neovascularization– The Submacular Surgery Trials Vision Preference Value Scale‌
    Williams R, Brody B, Thomas R, Caplan R, et al‌ The Psychosocial Impact of Macular Degeneration‌
    National Alliance for Eye and Vision Research (NAEVR)‌ The National Eye Institute (NEI) Responds to the Growing Public Health Problem of Age-Related Eye Disease‌
    National Institutes of Health, National Eye Institute‌ Progress in Eye and Vision Research: 1999-2006‌
    McCarty C, Nanjan M, Taylor H‌ Vision Impairment Predicts 5 Year Mortality‌
    Horowitz A, Reinhardt J, Kennedy G‌ Major and Subthreshold Depression Among Older Adults Seeking Vision Rehabilitation Services‌
    Clemons T, Rankin M, McBee W‌ Cognitive Impairment in the Age-Related Eye Disease Study: AREDS report no. 16‌
    Lott L, Haegerstrom-Portnoy G, Schneck M, Brabryn J‌ Face Recognition in the Elderly‌
    Sims R, McGwin G, Allman R, Ball K, et al‌ Exploratory Study of Incident Vehicle Crashes Among Older Drivers‌
    Ramrattan R, Wolfs R, Panda-Jones S, Jonas J, et al‌ Prevalence and Causes of Visual Field Loss in the Elderly and Associations with Impairment in Daily Functioning‌
    National Center for Health Statistics‌ Health, United States, 2006: With chartbook on trends in the health of Americans‌
    American Foundation for the Blind‌ Facts and Figures on Adults with Vision Loss‌
    Lee P, Feldman Z, Ostermann J, Brown D, et al.‌ Longitudinal Prevalence of Major Eye Diseases‌
    American Foundation for the Blind‌ Aging and Vision Loss Fact Sheet‌
    Varma R, Ying-Lai M, Francis B, Bao-Thu Nguyen B, et al‌ Prevalence of Open-Angle Glaucoma and Ocular Hypertension in Latinos: The Los Angeles Latino Eye Study‌
    Varma R, Torres M, Pena F, Klein R, et al‌ Prevalence of Diabetic Retinopathy in Adult Latinos: The Los Angeles Latino Eye Study‌
    Fong D, Aiello L, Gardner T, King G, et al.‌ Retinopathy in Diabetes‌
    National Alliance for Eye and Vision Research‌ Vision Impairment and Eye Disease is a Major Public Health Problem‌
    American Foundation for the Blind‌ Statistical Snapshots‌
    Chobanian A, Bakris G, Black H, Cushman W, et al.‌ Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure‌
    Franco O, Peeters A, Bonneux L, de Laet C‌ Blood Pressure in Adulthood and Life Expectancy with Cardiovascular Disease in Men and Women: Life course analysis‌
    Seshadri S, Beiser A, Kelly-Hayes M, Kase C, et al‌ The Lifetime Risk of Stroke: Estimates from the Framingham Study‌
    Jones D, Hall J‌ The National High Blood Pressure Education Program: Thirty years and counting‌
    Ng Y, Jacobs P, Johnson J‌ Productivity Losses Associated with Diabetes in the US‌
    National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases‌ National Diabetes Statistics‌
    National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH‌ Kidney Disease of Diabetes‌
    Redaelli A, Cranor C, Okano G, Reese R, et al‌ Screening, Prevention and Socioeconomic Costs Associated with the Treatment of Colorectal Cancer‌
    American Cancer Society‌ Assure Colon Cancer Screening‌
    McMeekin D, McGonigle K, Vasilev S‌ Cervical Cancer Prevention: Toward cost-effective screening‌
    National Institutes of Health, National Cancer Institute‌ Cervical Cancer Screening: Summary of evidence‌
    Centers for Disease Control and Prevention‌ Screening to Prevent Cancer Deaths‌
    Radice D, Redaelli A‌ Breast Cancer Management: Quality-of-life and cost considerations‌
    Centers for Disease Control and Prevention‌ Breast Cancer and Mammography Information‌
    Hempel K‌ The Health Gazette : Early Detection of Breast Cancer‌
    American Cancer Society‌ Breast Cancer Facts & Figures 2005-2006‌
    Tavazzi L‌ Clinical Epidemiology of Acute Myocardial Infarction‌
    International Early Lung Cancer Action Program Investigators‌ Survival of Patients with Stage I Lung Cancer Detected on CT Screening‌
    Burkhardt J, Sunshine J‌ Core-Needle and Surgical Breast Biopsy: Comparison of three methods of assessing cost‌
    Maisel A, Templin K, Love M, Clopton P‌ A Prospective Study of an Algorithm Using Cardiac Troponin I and Myoglobin as Adjuncts in the Diagnosis of Acute Myocardial Infarction and Intermediate Coronary Syndromes in a Veteran’s Hospital‌
    Johnston S, Rootenberg J, Katrak S, Smith W, et al.‌ Effect of a U.S. National Institute of Health Programme of Clinical Trials in Public Health and Costs‌
    American Diabetes Association‌ American Diabetes Association, Statistics About Diabetes‌
    Parkinson's Disease Foundation‌ Parkinson’s Disease: An overview‌
    Yarbroff R, Davis W, Lamont E, Fahey A, et al‌ Patient Time Costs Associated with Cancer Care‌
    Thorpe K, Howard D‌ The Rise in Spending Among Medicare Beneficiaries: The role of chronic disease prevalence and changes in treatment intensity‌
    Schoen C, Davis K, How S, Schoenbaum S‌ U.S. Health System Performance: A national scorecard‌
    Cleveland Clinic‌ Cleveland Clinic Unveils ‘Top 10’ Medical Innovations For 2010‌
    Asch S, Kerr E, Keesey J, Adams J, et al‌ Who Is at Greatest Risk for Receiving Poor-Quality Health Care?‌
    World Health Organization‌ Fact File‌
    Gambert S, Pinkstaff S‌ Emerging Epidemic: Diabetes in older adults–demography, economic impact, and pathophysiology‌
    National Insitutes of Health, National Institute on Aging‌ 2005-2006 Progress Report on Alzheimer’s Disease‌
    Alzheimer's Association‌ Alzheimer’s Disease Growth: U.S. will see average 44 percent increase in Alzheimer’s disease by 2025‌
    Spillman B, Black K‌ Staying the Course: Trends in family caregiving‌
    Caplan C, Brangan N‌ Out-of-Pocket Spending on Health Care by Medicare Beneficiaries Age 65 and Older in 2003‌
    Alzheimer's Association‌ 2007 Alzheimer’s Disease Facts and Figures‌
    Poisal J, Truffler C, Smith S, Sisko A, et al.‌ Health Spending Projections Through 2016: Modest changes obscure Part D’s impact‌
    PhRMA‌ 2005 Survey: Medicines in development for older Americans‌
    PhRMA‌ 2006 Report: Medicines in development for neurological disorders‌
    National Institutes of Health, National Institute of Diabetes & Digestive & Kidney Diseases‌ Am I at Risk for Diabetes?‌
    Murphy K, Topel R‌ The Value of Health and Longevity‌
    National Institutes of Health, National Center for Complementary and Alternative Medicine, NIH‌ National Center for Complementary and Alternative Medicine Report‌
    National Institutes of Health, National Institute of Neurological Disorders and Stroke, NIH‌ Parkinson’s Disease Information Page‌
    National Institutes of Health‌ National Diabetes Statistics: Incidence of diabetes‌
    Centers for Disease Control and Prevention‌ Heart Disease and Stroke Prevention‌
    American Cancer Society‌ Cancer Facts & Figures 2007‌
    Edwards B, Howe H, Ries L, Thun M, et al.‌ Annual Report to the Nation on the Status of Cancer, 1973-1999: Featuring implications of age and aging on U.S. cancer burden‌
    American Cancer Society‌ Colorectal Cancer Facts & Figures, Special Edition 2005‌
    Simmons A, Tarsy D‌ Parkinson’s Disease in Later Life‌
    Abdelgabar A, Sharma J‌ Sleep Disorders in Parkinson’s Disease‌
    Adler C‌ Nonmotor Complications in Parkinson’s Disease‌
    Lin O, Kozarek R, Schembre D, Ayub K, et al.‌ Screening Colonoscopy in Very Elderly Patients: Prevalence on neoplasia and estimated impact on life expectancy‌
    Kerlikowske K, Grady D, Rubin S, Sandrock C, et al.‌ Efficacy of Screening Mammography: A meta-analysis‌
    Pompei P‌ Diabetes Mellitus in Later Life‌
    O'Connell, John B‌ The Economic Burden of Heart Failure‌
    Hedner T‌ The Problem of Hypertension in the Elderly‌
    Vasan R, Beiser S, Seshadri S, Larson M, et al‌ Residual Lifetime Risk for Developing Hypertension in Middle-Aged Women and Men: The Framingham Heart Study‌
    Warshaw G‌ Introduction: Advances and challenges in care of older people with chronic illness‌
    Semla T, Rochon P‌ Pharmacotherapy‌
    Anderson G‌ Medicare and Chronic Conditions‌
    Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion‌ Chronic Disease Overview‌
    Wu S, Green A‌ Projection of Chronic Illness Prevalence and Cost Inflation‌
    Mensah G, Brown D‌ An Overview Of Cardiovascular Disease Burden In The United States: Data show a growing burden from cardiovascular disease in the U.S. population; now is the time to reverse those trends‌
    Zuvekas S, Cohen J‌ Prescription Drugs and the Changing Concentration of Health Care Expenditures‌
    Choudhry N, Avorn J, Antman E, Schneeweiss S, et al.‌ Should Patients Receive Secondary Prevention Medications For Free After A Myocardial Infarction? An economic analysis‌
    Wilson C, Fisher E, Welch H, Siewers A, et al‌ U.S. Trends in CABG Hospital Volume: The effect of adding cardiac surgery programs‌
    Catlin A, Cowan C, Heffler S, Washington B, et al.‌ National Health Spending In 2005: The slowdown continues‌
    Hayes K, Pettengill J, Stensland J‌ Getting The Price Right: Medicare payment rates for cardiovascular services‌
    Rosen A, Cutler D, Norton D, Hu H‌ The Value of Coronary Heart Disease Care for the Elderly: 1987-2002‌
    Cutler D, Long G, Berndt E, Royer J, et al.‌ The Value Of Antihypertensive Drugs: A perspective on medical innovation‌
    Redberg R‌ Evidence, Appropriateness, and Technology Assessment in Cardiology: A case study of computed tomography‌
    Califf R, Harrington R, Madre L, Peterson E, et al.‌ Curbing The Cardiovascular Disease Epidemic: Aligning industry, government, payers, and academics‌
    Pearson T‌ The Prevention Of Cardiovascular Disease: Have we really made progress?‌
    Weisfeldt M, Zeiman S‌ Advances in the Prevention and Treatment of Cardiovascular Disease: One of the most important contributors to improved human survival is the treatment of cardiovascular disease‌
    Gaziano, Thomas A‌ Reducing The Growing Burden Of Cardiovascular Disease In The Developing World‌
    Federal Interagency Forum on Aging-Related Statistics‌ Older Americans 2006: Key indicators of well-being‌
    PhRMA‌ Patient Impact of Medicines‌
    PhRMA‌ The Value of Medicines: Facts and figures 2006‌
    MEDTAP International, Inc‌ The Value of Investment in Health Care‌
    Hill J, Futterman R, Mastey V, Fillit H‌ The Effect of Donepezil Therapy on Health Costs in a Medicare Managed Care Plan‌
    Cowper P, DeLong E, Whellan D, LaPointe N, et al.‌ Economic Effects of Beta-Blocker Therapy in Patients with Heart Failure‌
    Lichtenberg F‌ The Expanding Pharmaceutical Arsenal in the War on Cancer‌
    Matchar D, Samsa G‌ Secondary and Tertiary Prevention of Stroke Patient Outcomes Research Team Final Report — Phase 1‌
    Lichtenberg F‌ Benefits and Costs of Newer Drugs: An update‌
    Alzheimer's Association‌ Alzheimer’s Disease and Chronic Health Conditions: The real challenge for 21st century Medicare‌
    Koppel R‌ Alzheimer’s Disease: The costs to U.S. businesses in 2002‌
    Centers for Disease Control and Prevention, National Center for Health Statistics‌ Mortality Data From the National Vital Statistics System‌
    Bynum J, Rabins P, Weller W, Niefeld M, et al.‌ The Relationship Between a Dementia Diagnosis, Chronic Illness, Medicare Expenditures, and Hospital Use‌
    National Institutes of Health‌ NIH Fact Sheet: Stroke‌
    Borger C, Smith S, Truffer C, Keehan S, et al.‌ Health Spending Projections Through 2015: Changes on the horizon‌
    National Institutes of Health, National Heart, Lung, and Blood Institute‌ The Healthy Heart Handbook for Women‌
    Langa K, Larson E, Weir D, Willis R, et al.‌ Out-of-Pocket Health Care Expenditures Among Older Americans With Dementia‌
    Centers for Disease Control and Prevention, Merk Institute of Aging and Health‌ The State of Aging and Health in America 2007‌
    Stern Y, Tang M, Albert M, Brandt J, et al‌ Predicting Time to Nursing Home Care and Death in Individuals with Alzheimer Disease‌
    Health Affairs‌ Trends in the Burden, Treatment, and Prevention of Cardiovascular Disease: Prologue‌
    Thorpe K, Florence C, Howard D, Joski P‌ The Impact of Obesity on Rising Medical Spending‌
    Pollack A‌ New Drug Holds Promise for Type of Breast Cancer‌
    Szabo L‌ New Weapons Do Battle with Kidney Cancer‌
    Alzheimer's Association‌ Saving Lives, Saving Money: Dividends for Americans investing in Alzheimer research‌
    PhRMA‌ Selected Medicines in Development for Cancer‌
    Lichtenberg F‌ The Impact of New Drug Launches on Longevity: Evidence from longitudinal disease-level data from 52 countries, 1982-2001‌
    Alzheimer's Association & National Alliance for Caregiving‌ Families Care: Alzheimer’s caregiving in the United States 2004‌
    Brown E‌ Cancer in the Crosshairs: Radiation oncologists are taking better aim at tumors with new software and super-precise radiation machines‌
    American Cancer Society‌ Cancer Facts & Figures 2006‌
    American Diabetes Association‌ Economic Costs of Diabetes in the U.S. in 2002‌
    Twelves C‌ Oral Chemotherapy Saves Resources and Time‌
    American Diabetes Association‌ The Dangerous Toll of Diabetes‌
    Genworth Financial‌ Genworth Finanical 2006 Cost of Care Survey: Nursing homes, assisted living facilities and home care providers‌
    Centers for Disease Control and Prevention, National Center for Health Statistics‌ Health, United States, 2005: With chartbook on trends in the health of Americans‌
    Minino A, Heron M, Smith B‌ Deaths: Preliminary data for 2004‌
    Centers for Disease Control and Prevention, National Center for Health Statistics‌ Health, United States, 2004: With chartbook on trends in the health of Americans‌
    Phiillips K, Shlipak M, Coxon P, Heidenreich P, et al.‌ Health and Economic Benefits of Increased Beta-Blocker Use Following Myocardial Infarction‌
    National Alliance for Caregiving and AARP‌ Caregiving in the U.S.‌
    Langa K, Chernew M, Kabeto M, Herzog A, et al.‌ National Estimates of the Quantity and Cost of Informal Caregiving for the Elderly with Dementia‌
    Partnership for Solutions‌ Chronic Conditions: Making the case for ongoing care-September 2004 update‌
    Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion‌ The Burden of Chronic Disease and the Future of Public Health: Presentation by Dr. James S. Marks‌
    MEDTAP International, Inc‌ The Value of Investment in Health Care: Better care, better lives‌
    Partnership for Solutions ‌ Chronic Conditions: Making the case for ongoing care‌
    Parkinson's Action Network‌ About Parkinson’s Disease‌
    Perrier A, Tabar V, Barberi T, Rubio M, et al.‌ Derivation of Midbrain Dopamine Neurons from Human Embryonic Stem Cells‌
    Leon J, Cheng C, Neumann P‌ Alzheimer s Disease Care: Costs and potential savings‌
    Brookmeyer R, Gray S, Kawas C‌ Projections of Alzheimer’s Disease in the United States and the Public Health Impact of Delaying Disease Onset‌
    Charles P, Padaliya B, Newman W, Gill C, et al.‌ Deep Brain Stimulation of the Subthalamic Nucleus Reduces Antiparkinsonian Medication Costs‌
    Caro J, Getsios D, Migliaccio-Walle K, Ishak J, et al.‌ Rational Choice of Cholinesterase Inhibitor for the Treatment of Alzheimer s Disease in Canada: A comparative economic analysis‌
    PhRMA Japan‌ Aricept Reduces Annual Treatment Cost by $1,000 Per Patient: Pfizer‌
    Provenzano G, Duttagupta S, McRae T, Mastey V, et al‌ Delays in Nursing Home Placement for Patients with Alzheimer s Disease Associated with Donepezil May Have Care Cost Savings Implications‌
    Reisberg B, Doody R, Stoffler A, Schmitt F, et al‌ Memantine in Moderate-to-Severe Alzheimer’s Disease‌
    Research!America‌ Investment in Research Saves Lives and Money‌
    Rodby R, Firth L, Lewis E‌ An Economic Analysis of Captopril in the Treatment of Diabetic Nephropathy‌
    National Diabetes Information Clearinghouse‌ Diabetes Prevention Program 04-5099‌
    National Institutes of Health, National Institute of Neurological Disorders and Stroke‌ New Stroke Treatment Likely to Decrease Health Care Costs and Increase Quality of Life‌
    Goldman D, Shang B, Bhattacharya J, Garber A, et al.‌ Consequences of Health Trends and Medical Innovation for the Future Elderly: Health and costs of the future elderly‌
    Giorgianni S, Grana J, Scipioni L‌ Global Impact of Innovations on Chronic Disease in the Genomics Era‌
    Managed Healthcare‌ Provide Education About Congestive Heart Failure and Pump Up Your Savings‌
    SOLVD Investigators‌ Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure‌
    Houston K‌ Innovative Drugs Cost Patients Less in the Long Run‌
    Xue F, Bettmann M, Langdon D, Wivell W‌ Outcome and Cost Comparison of Percutaneous Transluminal Renal Angioplasty, Renal Arterial Stent Placement, and Renal Arterial Bypass Grafting‌
    Cutler D, McClellan M‌ Is Technological Change in Medicine Worth It?‌
    Cutler D‌ Your Money or Your Life? Strong medicine for America’s health care system‌
    Yusuf S, Phil D, Zhao F, Mehta S, et al.‌ Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation‌
    Cutler D‌ Are the Benefits of Medicine Worth What We Pay for It? 15th Annual Herbert Lourie Memorial Lecture on Health Policy‌
    Joint Economic Committee‌ The Benefits of Medical Research and the Role of NIH‌
    Jelinek J, Murphey M, Welker J, Henshaw R, et al.‌ Diagnosis of Primary Bone Tumors with Image-Guided Percutaneous Biopsy: Experience with 110 tumors‌
    Lichtenberg F‌ Do (More and Better) Drugs Keep People Out of Hospitals?‌
    Lichtenberg F‌ Longer Living Through Chemistry‌
    Centers for Disease Control and Prevention, Merck Institute of Aging and Health‌ The State of Aging and Health in America 2004‌
    U.S. Census Bureau‌ Projections of the Total Resident Population by 5-Year Age Groups, Race, and Hispanic Origin with Special Age Categories: Middle series, 2025 to 2045‌
    Friedland R, Summer L‌ Demography Is Not Destiny, Revisited‌
    Hing E, Middleton K‌ National Hospital Ambulatory Medical Care Survey: 2002 outpatient department summary‌
    Peck P‌ Alzheimer’s Disease Costs Expected to Triple: Sharpest increase seen among blacks‌
    Cummings J, Cole G‌ Alzheimer Disease‌
    Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion‌ A Public Health Action Plan to Prevent Heart Disease and Stroke‌
    Mayo Clinic, College of Medicine‌ Parkinson’s Disease Information‌
    Partnership for Solutions‌ Alzheimer’s Disease: The impact of multiple chronic conditions‌
    Parkinson's Action Network‌ What is Parkinson’s Disease?‌
    Parkinson's Disease Foundation‌ Ten Frequently-Asked Questions about Parkinson’s Disease‌
    National Institutes of Health, National Institute of Neurological Disorders and Stroke‌ Parkinson’s Disease: Challenges, progress, and promise‌
    Boyle J, Honeycutt A, Venkat Narayan K, Hoerger T, et al.‌ Projection of Diabetes Burden Through 2050: Impact of changing demography and disease prevalence in the U.S‌
    PhRMA‌ Diabetes and Pharmaceutical Spending: New treatments, new solutions‌
    Hurst W‌ The Heart, Arteries and Veins 10th Ed‌
    Goldman D, Cutler D, Shang B, Joyce G‌ The Value of Elderly Disease Prevention‌
    Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion‌ National Center for Chronic Disease Prevention and Health Promotion Home Page‌
    National Institutes of Health, National Heart, Lung, and Blood Institute‌ Framingham Heart Study‌
    Steinwachs D, Collins-Nakai R, Cohn L, Garson A, et al‌ The Future of Cardiology: Utilization and costs of care‌
    Joyce G, Keeler E, Shang B, Goldman D‌ The Lifetime Burden of Chronic Disease among the Elderly: Health and costs of the future elderly‌
    Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion‌ The Burden of Chronic Diseases and Their Risk Factors: National and state perspectives‌
    Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion‌ Preventing Heart Disease and Stroke‌
    Seifelden R, Hantsch J‌ The Economic Burden Associated with Colon Cancer in the United States‌
    Hayman J, Langa K, Kabeto M, Katz S, et al.‌ Estimating the Cost of Informal Caregiving for Elderly Patients with Cancer‌
    Pfizer Inc‌ The Burden of Cancer in American Adults‌
    Brown M, Lipscomb J, Snyder C‌ The Burden of Illness and Cancer: Economic cost and quality of life‌
    Woodwell D, Cherry D‌ National Ambulatory Medical Care Survey: 2002 Summary‌
    National Institutes of Health, National Institute on Aging‌ Age Page: Cancer facts for people over 50‌
    American Cancer Society‌ Cancer Facts & Figures 2005‌
    U.S. General Accounting Office‌ Long-Term Care: Aging baby boom generation will increase demand and burden on federal and state budgets, Statement of David M. Walker Comptroller General of the United States‌
    Hoffman C, Rice D‌ Chronic Care in America: A 21st century challenge‌
    Medical News Today‌ Coping with Multiple Chronic Conditions‌
    Wolff J, Starfield B, Anderson G‌ Prevalence, Expenditures, and Complications of Multiple Chronic Conditions in the Elderly‌
    Alliance for Health Reform‌ Covering Health Issues: A sourcebook for journalists 2004‌
    Alliance for Aging Research‌ Medical Never-Never Land: Ten reasons why America is not ready for the coming age boom‌